Schedule XIV – Norway                                                                                               Page 5                WT/Let/654  
 
 
  
SCHEDULE XIV – NORWAY 
 
 
 
    
 
7 August 2009   
Schedule XIV – Norway – Proposed INN list   Page 6  WT/Let/654   
ANNEX I  
Proposed INN lists 79-93  
Sorted by INN name ascending  
 
 WCO HS Classifications have been decide d by WCO and are then definitive (except 
someones still under examination).   ID 777, 778, 779 and 833 are old INNs and have not been classified by WCO so the codes are those proposed by EU. 
 
ID # HS Code INN Name CAS-RN Propos. INN List
1 2934 99 abaperidone 183849-43-6 80
2 3002 10 abatacep t 332348-12-6 91
3 2934 99 abetimus 167362-48-3 81
4 2937 19 abrineurin 178535-93-8 84
5 2934 99 acolbifene 182167-02-8 86
6 2934 10 acotiamide 185106-16-5 91
7 3002 10 adalimumab 331731-18-1 82+85
8 2934 99 adargileukin alfa 250710-65-7 89
9 3002 10 adecatumumab 503605-66-1 90
10 2933 39 adekalant 227940-00-3 83
11 2934 99 adrogolide 171752-56-0 82
12 2939 99 afeletecan  215604-75-4 85+86
13 3507 90 agalsidase alfa 104138-64-9 84
14 3507 90 agalsidase beta 104138-64-9 84
15 2934 10 alagebrium chloride 341028-37-3 91
16 2933 59 alamifovir 193681-12-8 89
17 2933 59 albaconazole 187949-02-6 87
18 3002 10 alefacep t 222535-22-0 84
19 2932 29 alemcinal 150785-53-8 82
20 3002 10 alemtuzumab 216503-57-0 83
21 2907 29 alfatradiol 57-91-0 84
22 3507 90 alfimeprase 259074-76-5 85
23 3507 90 alglucosidase alfa 420784-05-0 91
24 2934 99 alicaforsen 185229-68-9 85
25 2933 49 alilusem 144506-11-6 85
26 2924 29 aliskiren 173334-57-1 83+84
27 2936 21 alitretinoin 5300-03-8 80
28 2933 99 altinicline 179120-92-4 82
29 2933 39 alvameline 120241-31-8 79
30 2933 39 alvimopan 156053-89-3 87
31 2934 99 alvocidib 146426-40-6 88
32 2933 59 ambrisentan 177036-94-1 85
33 2934 99 amdoxovir 145514-04-1 85 
 
Schedule XIV – Norway – Proposed INN list              Page 7   WT/Let/654   ID # HS Code INN Name CAS-RN Propos. INN List
34 3507 90 amediplase 151912-11-7 79
35 2925 20 amelubant 346735-24-8 85+86
36 2924 29 amiglumide 119363-62-1 82+85
38 2932 29 amotosalen 161262-29-9 85
39 2935 00 amprenavir 161814-49-9 79
40 2935 00 anatibant 209733-45-9 88
41 3002 10 anatumomab mafenatox 0-00-0 79+86
42 3002 10 ancestim 163545-26-4 79
721 2933 39 ancriviroc 370893-06-4 92
43 2937 29 anecortave 7753-60-8 80
44 2941 90 anidulafungin 166663-25-8 81
45 2925 20 anisperimus 170368-04-4 82
780 3002 10 antithrombin alfa 84720-88-7 93
46 2933 99 apaziquone 114560-48-4 87
781 2933 79 apixaban 503612-47-3 93
473 2934 99 aplindore (palindore) 189681-70-7 87+92
47 3002 10 apolizumab 267227-08-7 87
782 2935 00 apratastat 287405-51-0 93
48 2934 99 aprepitant 170729-80-3 84
49 2934 99 aprinocarsen 151879-73-1 89
783 2934 99 arasertaconazole 583057-48-1 93
50 2934 99 ardenermin 305391-49-5 88
51 2924 29 arformoterol 67346-49-0 90
52 2933 39 arimoclomol 289893-25-0 88
53 2930 90 armodafinil 112111-43-0 91
722 2934 99 artemifone 255730-18-8 92
54 2932 99 artemotil 75887-54-6 80
55 2932 99 artenimol 81496-81-3 81
56 2915 90 arundic acid 185517-21-9 88
57 2934 99 arzoxifene 182133-25-1 80
58 2932 29 ascorbyl gamolenate 109791-32-4 79
59 3002 10 aselizumab 395639-53-9 88
60 2934 99 asenapine 65576-45-6 87+89
61 2937 29 asoprisnil 199396-76-4 86+88
62 2937 29 asoprisnil ecam ate 222732-94-7 88+89
63 2935 00 ataciguat 254877-67-3 88
64 2933 99 ataquimast 182316-31-0 82
65 2933 39 atazanavir  198904-31-3 88
723 2933 99 atilmotin 533927-56-9 92
66 2909 49 atocalcitol 302904-82-1 88
67 3002 10 atorolimumab 202833-08-7 80
68 2934 99 atrasentan 195733-43-8 83
724 2933 59 avanafil 330784-47-9 92Schedule XIV – Norway – Proposed INN list               Page 8  WT/Let/654  ID # HS Code INN Name CAS-RN Propos. INN List
69 2929 90 avasimibe 166518-60-1 80
70 3002 90 aviscumine 223577-45-5 84+86
784 2935 00 avosentan 290815-26-8 93
71 2924 29 axitirome 156740-57-7 82
72 2922 50 axomadol 187219-95-0 87+89+90
73 2934 10 balaglitazone 199113-98-9 84
725 2933 59 balicatib 354813-19-7 92
74 2933 39 bamirastine 215529-47-8 91
75 2929 90 banoxantrone 136470-65-0 90
785 3002 10 bapineuzumab 648895-38-9 93
76 2933 39 barixibat 263562-28-3 88
77 2934 99 barusiban 285571-64-4 88
78 2935 00 batabulin 195533-53-0 90
79 2933 99 bazedoxifene 198481-32-2 86
80 2933 99 becampane l 188696-80-2 90
726 [2934 99] 
[2938 90] 
[2941 90] becatecarin 1 19673-08-4 92
727 2906 19 becocalcidiol 524067-21-8 92
81 2934 99 befetupitant 290296-68-3 91
786 3002 10 belat acept 706808-37-9 93
82 3002 10 belimumab 356547-88-1 89
83 2939 99 belotecan 256411-32-2 91
84 2934 99 beminafil 566906-50-1 90
728 2933 69 bemotrizinol 187393-00-6 92
85 3002 10 bertilimumab 375348-49-5 88
729 3002 10 besilesomab 537694-98-7 92
86 3002 10 bevacizumab 216974-75-3 83+86
87 2916 39 bexarotene 153559-49-0 80
88 2933 79 bexlosteride 148905-78-6 81
89 2933 29 bifarcept 163796-60-9 86
90 2934 99 bifeprunox 350992-10-8 87
91 2933 39 bilastine 202189-78-4 82
92 2937 50 bimatoprost 155206-00-1 85
93 2940 00 bimosiamose 187269-40-5 84
94 3002 10 binetrakin 207137-56-2 82
95 2934 99 binodenoson 144348-08-3 90
730 2933 99 bisoctrizole 103597-45-1 92
96 3002 10 bivatuzumab 214559-60-1 83+86
97 2933 99 bortezomib 179324-69-7 88
787 2933 79 brivaracet am 357336-20-0 93
98 2933 99 brostallicin 203258-60-0 84
99 2934 99 bulaquine 223661-25-4 82
100 2933 59 cadrofloxacin 153808-85-6 81+86
101 2933 99 calcobutrol 151878-23-8 79 
 
Schedule XIV – Norway – Proposed INN list              Page 9   WT/Let/654   ID # HS Code INN Name CAS-RN Propos. INN List
102 2933 59 caldaret 133804-44-1 85
103 2922 50 caloxetic acid 135306-78-4 81
104 2934 99 canertinib 267243-28-7 87
731 2930 90 canfosfamide 158382-37-7 92
105 2934 99 cangrelor 0-00-0 82
106 3002 10 cantuzumab mertansine 400010-39-1 89
107 2933 39 capravirine 178979-85-6 83
108 2933 99 capromorelin 193273-66-4 83
109 2932 99 carabersat 184653-84-7 80+85
110 2924 19 carglumic acid 1188-38-1 84
788 2933 39 caricotamide 64881-21-6 93
111 2933 79 carmoterol 147568-66-9 91
112 2941 90 caspofungin 162808-62-0 80
789 3002 10 catumaxomab 509077-98-9 93
113 2941 90 cefmatilen 140128-74-1 81
114 2941 90 cefovecin 234096-34-5 87
732 2941 90 ceftobiprole 209467-52-7 92
733 2941 90 ceftobiprole medocaril 376653-43-9 92
115 2935 00 celecoxib 169590-42-5 80
116 3002 10 certolizumab pegol 428863-50-7 90
117 2941 90 cethromycin 205110-48-1 87
118 2934 99 cetilistat 282526-98-1 91
119 3002 10 cetuximab 205923-56-4 82
120 2933 79 cilengitide 188968-51-6 81
121 2926 90 cilomilast 153259-65-5 82
122 2934 10 ciluprevir 300832-84-2 90
123 2935 00 cimicoxib 265114-23-6 89
124 2921 49 cinacal cet 226256-56-0 88
734 [2934 99] 
[3002 10]  cintredekin besudotox 372075-36-0 92
125 2933 39 cipemastat 190648-49-8 81
126 2933 29 cipralisant 213027-19-1 85
127 2935 00 clamikalant 158751-64-5 81
128 2935 00 clazosentan 180384-56-9 90
129 2934 99 clofarabine 123318-82-1 90
130 2934 99 coluracet am 135463-81-9 86
131 2933 99 conivaptan 210101-16-9 82
132 2934 99 corifollitropin alfa 195962-23-3 80
133 2933 99 cridanimod 38609-97-1 83
134 2933 39 crobenetine 0-00-0 82
136 2933 39 dabigatran 211914-51-1 83
137 2933 39 dabigatran etexilate 211915-06-9 87
138 2935 00 dabuzalgron 219311-44-1 89Schedule XIV – Norway – Proposed INN list               Page 10  WT/Let/654  ID # HS Code INN Name CAS-RN Propos. INN List
139 2933 99 dacinostat 404951-53-7 89
140 2933 79 daglutril 182821-27-8 90
141 2941 90 dalbavancin 171500-79-1 85+86+90
790 2933 29 dapiclermine 444069-80-1 93
142 2933 59 dapivirine 244767-67-7 86
143 3002 10 darbepoetin alfa 209810-58-2 85
144 2934 10 darbufelone 139226-28-1 80
145 2935 00 darunavir 206361-99-1 88
146 2933 59 darusentan 171714-84-4 82
147 2933 59 dasantafil 569351-91-3 91
735 [2924 19] 
[2924 29] davasaicin 147497-64-1 92
148 2934 99 daxalipram 189940-24-7 91
149 2933 99 deferasirox 201530-41-8 86
736 2934 10 deferitrin 239101-33-8 92
150 2932 99 defoslimod 171092-39-0 79
151 2937 19 degarelix 214766-78-6 86
152 3913 90 deligoparin sodium 9041-08-1 89
737 2925 20 delmitide 287096-87-1 92
153 2921 49 delucemine 186495-49-8 87
154 2934 99 denufosol 211448-85-0 91
155 2934 99 depelestat 506433-25-6 91
156 2933 79 depreotide 161982-62-3 80
157 2935 00 deracoxib 169590-41-4 80
158 2933 39 dersalazine 188913-58-8 86
159 2933 39 desloratadine 100643-71-8 80
833 2930 90 desmeninol 583-91-5 70
160 3507 90 desmoteplase 145137-38-8 80
161 2922 50 desvenlafaxine 93413-62-8 89
162 2933 59 detiviciclovir 220984-26-9 86
738 2845 90 deutolperisone 474641-19-5 92
163 2932 99 dexbudesonide 51372-29-3 80
791 2933 39 dexlansoprazole 138530-94-6 93
164 2933 39 dexmethylphenidate 40431-64-9 88
165 2930 90 dextiopronin 29335-92-0 79
166 2933 99 dextofisopam 82059-50-5 90
792 2934 99 dianicline 292634-27-6 93
167 2933 29 dibotermin alfa 246539-15-1 89
168 2939 99 diflomotecan 220997-97-7 84
169 2934 99 diquafosol 59985-21-6 89
170 2933 99 dirlotapide 481658-94-0 91
171 2932 29 disermolide 127943-53-7 89
172 2929 90 disufenton sodium 168021-79-2 88
173 2933 59 dofequidar 129716-58-1 88
174 2933 59 donitriptan 170912-52-4 82 
 
Schedule XIV – Norway – Proposed INN list              Page 11   WT/Let/654   ID # HS Code INN Name CAS-RN Propos. INN List
175 2934 99 doramapimod 285983-48-4 88
176 2933 29 doranidazole 149838-23-3 90
177 2941 90 doripenem 148016-81-3 83
178 2936 29 doxercalciferol 54573-75-0 82
179 3002 10 drotrecogin alfa (activated) 98530-76-8 85+86
180 2933 39 ecalcidene 150337-94-3 85
793 2934 99 ecallantide 460738-38-9 93
181 2933 99 ecopipam 112108-01-7 80
182 2935 00 ecopladib 381683-92-7 90
183 2937 50 ecraprost 136892-64-3 83
184 3002 10 ecromeximab 292819-64-8 87
185 3002 10 eculizumab 219685-50-4 87
186 2934 10 edaglitazone 213411-83-7 91
187 2934 99 edifoligide 328538-04-1 89
188 3002 10 edodekin alfa 187348-17-0 79
189 2935 00 edonentan 210891-04-6 86
190 2934 99 edotecarin 174402-32-5 87
191 2934 99 edotreotide 204318-14-9 84
192 2933 99 edratide 433922-67-9 89
193 2922 19 edronocaine 190258-12-9 84
194 3002 10 efalizumab 214745-43-4 85
195 2924 29 efaproxiral 131179-95-8 86
739 2935 00 efipladib 381683-94-9 92
196 2930 90 eflucimibe 202340-45-2 84
197 2937 50 eganoprost 63266-93-3 84
198 2922 49 eglumetad (eglumegad) 176199-48-7 87+90
199 2933 39 elarofiban 198958-88-2 83
740 2939 99 elomotecan 220998-10-7 92
200 3002 10 elsilimomab 468715-71-1 89
201 2934 99 elvucitabine 181785-84-2 89
202 2934 99 elzasonan 361343-19-3 87+89
741 [2933 99] 
[2934 99] embeconazole 329744-44-7 92
204 2933 29 emfilermin 159075-60-2 82
205 2933 59 emivirine 149950-60-7 82
206 2934 99 emodepside 155030-63-0 84
207 2934 99 emtricitabine 143491-57-0 80
208 2933 59 enecadin  259525-01-4 87+89
209 2933 29 enfuvirtide 159519-65-0 85
210 2933 99 eniporide 176644-21-6 79
211 2932 99 enrasentan 167256-08-8 80+86
213 2933 59 entecav ir 142217-69-4 82
215 2933 39 enzastaurin 170364-57-5 90Schedule XIV – Norway – Proposed INN list               Page 12  WT/Let/654  ID # HS Code INN Name CAS-RN Propos. INN List
216 3507 90 epafipase 208576-22-1 85
217 3002 10 epitumomab 0-00-0 82
218 3002 10 epitumomab cituxetan 263547-71-3 89
219 2928 00 eplivanserin 130579-75-8 80
220 3002 10 epoetin delta 261356-80-3 85
742 [2937 90] 
[3002 10] epoetin zeta 604802-70-2 92
221 3002 10 epratuzumab 205923-57-5 82
222 2933 69 eptapirone 179756-85-5 82
223 2843 90 eptaplatin 146665-77-2 83
224 2933 29 eptotermin alfa 129805-33-0 89
743 [2932 99] 
[2938 90] eritoran 185955-34-4 92
225 3002 10 erlizumab 211323-03-4 84
226 2933 59 erlotinib 183321-74-6 85
227 2941 90 ertapenem 153832-46-3 84
228 2934 99 ertiprotafib 251303-04-5 87
794 3002 10 ertumaxomab 509077-99-0 93
229 2932 99 escitalopram 128196-01-0 82
230 2922 39 esketamine 33643-46-8 81
231 2933 99 eslicarbazepine 104746-04-5 90
795 2933 59 esmirtazapine 61337-87-9 93
232 2933 39 esomeprazole 119141-88-7 79
233 2930 90 esonarimod 101973-77-7 79
234 2922 19 esoxybutynin 119618-22-3 90
235 2933 79 eszopiclone 138729-47-2 87
744 2918 90 etalocib 161172-51-6 92
236 3002 10 etanercept 185243-69-0 81
238 2922 50 etilevodopa 37178-37-3 80
239 2937 22 etiprednol di cloacetate 199331-40-3 88
240 2933 39 etoricoxib 202409-33-4 84
241 2933 59 etravirine 269055-15-4 88
242 2933 59 etriciguat 402595-29-3 88
243 3507 90 eufauserase 0-00-0 84
244 2941 90 evernimicin 109545-84-8 82+85+86
245 2934 99 everolimus 159351-69-6 82
246 2939 99 exatecan  171335-80-1 81
247 2939 99 exatecan alideximer 0-00-0 89
248 3002 10 exbivirumab 569658-80-6 91
249 2933 29 exenatide 141758-74-9 89
250 2930 90 exisulind 59973-80-7 80
251 2933 79 ezetimib e 163222-33-1 83
252 2933 39 ezlopitant 147116-64-1 82
253 2933 29 fadolmidine (radolmidine) 189353-31-9 82+86
254 2933 59 falnidamol 196612-93-8 81 
 
Schedule XIV – Norway – Proposed INN list              Page 13   WT/Let/654   ID # HS Code INN Name CAS-RN Propos. INN List
255 2933 29 fampronil 134183-95-2 91
256 2934 99 fanapanel 161605-73-8 80
257 2934 99 fandosentan 221241-63-0 87
745 2934 99 farampator 211735-76-1 92
258 2934 99 farglit azar 196808-45-4 84
259 2934 10 febuxostat 144060-53-7 85+86
260 2933 59 feloprentan 204267-33-4 85
261 2922 50 fesoterodine 286930-03-8 84
262 2933 39 fidexaban 183305-24-0 91
263 2934 99 fiduxosin 208993-54-8 82
264 2933 59 figopitant 0-00-0 82
265 2934 99 finafloxacin 209342-40-5 85+86
266 2922 19 fingolimod 162359-55-9 91
267 2933 99 finrozole 160146-17-8 81+86
268 2933 29 fipamezole 150586-58-6 88
269 2932 29 firocoxib 189954-96-9 89
270 2909 49 fispemifene 341524-89-8 89
271 2933 79 flindokalner 187523-35-9 86
272 2932 29 fluorescein lisicol 140616-46-2 89
273 2932 99 fondaparinux sodium 114870-03-0 79+83
274 3002 10 fontolizumab 326859-36-3 87
746 2933 59 forodesine 209799-67-7 92
275 2935 00 fosamprenavir 226700-79-4 83
276 2933 99 fosfluconazole 194798-83-9 83
796 2934 99 fosfluridine tidoxil 174638-15-4 93
277 2940 00 fosfructose 488-69-7 81
278 2922 50 fosveset 193901-91-6 83
279 2924 29 frakefamide 188196-22-7 81
280 2934 99 freselestat 208848-19-5 89
281 2846 90 gadocoletic acid 280776-87-6 85+86
282 2846 90 gadodenterate 544697-52-1 91
283 2846 90 gadofosveset 193901-90-5 83+86
284 2846 90 gadomelitol 227622-74-4 85+86
285 2941 90 galarubicin 140637-86-1 80
286 3002 10 galiximab 357613-77-5 89
747 3507 90 galsulfase 552858-79-4 92
287 2934 99 ganstigmine 0-00-0 81
288 2933 49 gantacurium chloride 213998-46-0 91
289 2934 99 gantofiban 183547-57-1 80
290 2933 49 garenoxacin 194804-75-6 87
291 3002 10 garnocestim 246861-96-1 85+86
292 3002 10 gavilimomab 244096-20-6 84
293 2934 99 gefitinib 184475-35-2 85Schedule XIV – Norway – Proposed INN list               Page 14  WT/Let/654  ID # HS Code INN Name CAS-RN Propos. INN List
294 2918 90 gemcabene 183293-82-5 88
295 2933 99 gemifloxacin 204519-64-2 81
296 2933 79 gemopatrilat 160135-92-2 84
297 3002 10 gemtuzumab 220578-59-6 83
298 2939 99 gimat ecan 292618-32-7 86
299 2933 39 gimeracil 103766-25-2 80
748 3507 90 glucarpidase 9074-87-7 92
300 3002 10 golimumab 476181-74-5 91
301 3002 10 hemoglobin glutamer 0-00-0 80
302 3002 10 hemoglobin raffimer 197462-97-8 89
749 [2933 29] 
[2937 50] [3002 10] iboctadekin 479198-61-3 92
306 3002 10 ibritumomab tiuxetan 206181-63-7 81+86
307 2931 00 ibrolipim 133208-93-2 88
308 2933 39 icaridin 119515-38-7 86
309 2934 99 iclaprim 192314-93-5 88
310 2922 49 icofungipen 198022-65-0 89
750 2918 19 icomucret 54845-95-3 92
311 2933 99 icrocaptide 169543-49-1 89
312 2932 99 idraparinux sodium 149920-56-9 83+84
313 2941 50 idremcinal 110480-13-2 81
314 2932 99 idronoxil 81267-65-4 91
315 3507 90 idursulfase (idusulfase) 50936-59-9 87+89+ 90
316 2933 39 iferanserin 58754-46-4 89
317 2935 00 iguratimod 123663-49-0 86
318 2933 39 ilaprazole 172152-36-2 86
319 3002 10 ilodecak in 149824-15-7 81
320 2933 59 imatinib 152459-95-5 84+86
321 2933 29 imidafenacin 170105-16-5 90
322 2934 99 imiglit azar 250601-04-8 91
323 2933 99 implitapide 177469-96-4 82
324 2933 79 indacater ol 312753-06-3 91
325 2933 39 indibulin 204205-90-3 91
326 2934 99 indiplon 325715-02-4 86
327 2935 00 indisulam 165668-41-7 86
328 2906 19 inecalc itol 163217-09-2 87
329 2933 99 ingliforib 186392-65-4 85
751 3002 10 inotuzumab ozogamicin 635715-01-4 92
330 2934 99 insulin detemir 169148-63-4 80
331 2937 19 insulin glulisine 207748-29-6 84
332 2924 29 iosimenol 181872-90-2 88
333 2933 39 ipravacai ne 166181-63-1 85
334 2934 99 irampanel 206260-33-5 82
335 2914 40 irofulven 158440-71-2 82+85 
 
Schedule XIV – Norway – Proposed INN list              Page 15   WT/Let/654   ID # HS Code INN Name CAS-RN Propos. INN List
336 2934 99 iroxanadine 276690-58-5 87
752 2922 50 isalmadol 269079-62-1 92
337 2934 99 isatoribine 122970-40-5 83
338 2934 99 iseganan 257277-05-7 85
339 2934 99 ismomultin alfa 457913-93-8 91
753 2933 59 ispinesib 336113-53-2 92
797 2933 39 ispronicline 252870-53-4 93
798 2928 00 istaroxime 203737-93-3 93
340 2939 59 istradefylline 155270-99-8 89
341 2933 39 itriglumide 201605-51-8 82
342 2933 39 iturelix 112568-12-4 79
343 2941 90 ixabepilone 219989-84-1 89
344 2934 20 izonsteride 176975-26-1 81
345 3002 10 labetuzumab 219649-07-7 85
346 2937 19 labradimil 159768-75-9 83
347 2924 29 lacosamide (erlosamide) 175481-36-4 85+90
348 2941 90 ladirubicin 171047-47-5 83
349 2924 29 ladostigil 209394-27-4 89
350 2933 39 lanicemine 153322-05-5 82
351 2934 99 lanimostim 117276-75-2 91
352 2933 49 laniquidar 197509-46-9 85
353 2934 99 lapatinib 231277-92-2 89
354 2933 79 lapisteride 142139-60-4 85+86
355 2933 79 laquinimod 248281-84-7 85
356 3507 90 laronidase 210589-09-6 85+86
357 2933 99 lasofoxifene 180916-16-9 81
358 2941 90 latidectin 371918-51-3 
(component A3), 
371918-44-4 
(component A4) 88
359 2934 99 leconotide 247207-64-3 86
799 2934 99 lecozotan 434283-16-6 93
360 3002 10 lemalesomab 250242-54-7 84+86
361 2933 99 lemuteporfin 215808-49-4 91
362 2933 79 lenalidomide 191732-72-6 91
363 3002 10 lerdelimumab 285985-06-0 83+86
364 2934 99 leridistim 193700-51-5 80
365 2934 99 lestaurtinib 111358-88-4 91
366 2933 59 leteprinim 138117-50-7 80
367 2921 49 levmetamfetamine 33817-09-3 83
800 2933 39 levolansoprazole 138530-95-7 93
754 2933 99 levotofisopam 82059-51-6 92
368 2934 99 liatermin 188630-14-0 81
369 3002 10 libivirumab 569658-79-3 91Schedule XIV – Norway – Proposed INN list               Page 16  WT/Let/654  ID # HS Code INN Name CAS-RN Propos. INN List
370 2933 99 licarbazep ine 29331-92-8 81
371 2933 99 licofelone 156897-06-2 86
372 2931 00 lidadronic acid 63132-38-7 84
373 2934 20 lidorestat 245116-90-9 87
755 2933 99 linaprazan 248919-64-4 92
374 2937 19 liraglutide 204656-20-2 87
375 2932 99 lirimilast 329306-27-6 85+86
376 2935 00 litomeglovir 321915-31-5 84
377 3913 90 livaraparin calcium 329306-27-6 85+86
378 2933 99 lixivaptan 168079-32-1 83
379 2934 99 lomeguatrib 192441-08-0 89
380 2933 39 lonafarnib 193275-84-2 86
381 2933 59 lopinavir 192725-17-0 80
382 2934 99 lubazodone 161178-07-0 86
383 2937 50 lubiprostone 333963-40-9 87+89
384 2934 99 luliconazole 187164-19-8 86
385 3002 10 lumiliximab 357613-86-6 90
386 2922 49 lumiracoxib 220991-20-8 87
387 2934 20 lurasidone 367514-87-2 88+90
388 2934 99 lusaperidone 214548-46-6 82
389 2933 29 lusupultide 200074-80-2 80
390 2934 99 manifaxine 135306-39-7 85
801 2926 90 manitimus 202057-76-9 93
391 2922 19 mantabegron 36144-08-8 88
802 3002 10 mapatumumab 658052-09-6 93
392 2933 39 maraviroc 376348-65-1 91
393 2934 99 maribavir 176161-24-3 80
777 2928 00 marimastat 154039-60-8 75
394 2933 39 maropitant 147116-67-4 90
395 3002 10 matuzumab 339186-68-4 88
396 2933 29 mecasermin ri nfabate 478166-15-3 91
397 2933 49 meclinertant (reminertant) 146362-70-1 85+88
398 2928 00 meldonium 76144-81-5 86
399 2922 50 melevodopa 7101-51-1 83
400 3002 10 mepolizumab 196078-29-2 81
402 2934 99 merimepodib 198821-22-6 87
403 3002 10 metelimumab 272780-74-2 86+88
404 2937 19 metreleptin 186018-45-1 82
405 2941 90 micafungin 235114-32-6 84
406 2933 59 midafotel 117414-74-1 79
407 2939 59 midaxifylline 151159-23-8 79
408 2934 99 midostaurin 120685-11-2 79
409 2933 39 miglustat 72599-27-0 85
410 2932 19 milataxel 393101-41-2 91 
 
Schedule XIV – Norway – Proposed INN list              Page 17   WT/Let/654   ID # HS Code INN Name CAS-RN Propos. INN List
411 2933 39 minopafant 128420-61-1 80+86
412 3002 10 minretumomab 195189-17-4 80
413 2843 90 miriplatin 141977-79-9 85
414 2934 99 mirococept 507453-82-9 91
415 3002 10 mirostipen 244130-01-6 85
416 2932 29 mitemcinal 154738-42-8 86
417 2934 99 mitratapid 179602-65-4 88
418 3002 10 mitumomab 216503-58-1 82
419 2934 10 mivotilate 130112-42-4 80
420 3002 10 morolimumab 202833-07-6 79
756 2939 19 morphine glucuronide 20290-10-2 92
421 2933 99 motexafin 189752-49-6 82+83
422 2933 99 mozavaptan 137975-06-5 87
423 2933 99 mozenavir 174391-92-5 84
424 2934 99 mubritinib 366017-09-6 90
425 2934 99 muraglit azar 331741-94-7 90
426 3906 90 murelet ecan 246527-99-1 85+86
427 2939 19 nalfurafine 152657-84-6 87+90
428 2926 90 naminidil 220641-11-2 87
429 3507 90 nasaruplase beta 136653-69-5 85+86
430 3002 10 natalizumab 189261-10-7 79
757 2918 90 naveglit azar 476436-68-7 92
431 2934 99 navuridine 84472-85-5 84
432 2939 59 naxifylline 166374-49-8 86
433 2935 00 nebentan 403604-85-3 90
803 2914 70 nebicapone 274925-86-9 93
434 2924 29 neboglamine (nebostinel) 163000-63-3 82+85
435 2933 99 nemifitide 173240-15-8 87
436 2921 30 neramexane 219810-59-0 84
804 2933 39 nerispirdine 119229-65-1 93
437 2934 99 nesiritide 124584-08-3 80
438 2934 10 netoglitazone 161600-01-7 85
439 2933 59 netupitant 290297-26-6 90
440 2922 29 nolomirole 90060-42-7 84
441 2937 29 norelgestromin 53016-31-2 83+84
442 2933 99 nortopixantrone 156090-17-4 87
443 2934 99 oblimersen 190977-41-4 87
446 2934 99 odiparcil 137215-12-4 89
805 3002 10 ofatumumab 679818-59-8 93
447 2933 99 oglufanide 38101-59-6 86
448 2933 49 olamufloxacin 167887-97-0 79+86
449 2925 20 olanexidine 146510-36-3 81
450 2933 59 olcegepant 204697-65-4 86Schedule XIV – Norway – Proposed INN list               Page 18  WT/Let/654  ID # HS Code INN Name CAS-RN Propos. INN List
806 2933 29 olmesartan 144689-24-7 93
451 2934 99 olmesartan medoxomil 
(olmesartan) 144689-63-4 80+82+86
452 2933 59 omaciclovir 124265-89-0 84
453 3002 10 omalizumab 242138-07-4 84
454 2933 99 omiganan 204248-78-2 89
455 2932 99 omigapil 181296-84-4 90
758 2933 99 omocianine 154082-13-0 92
456 2934 99 onercept 199685-57-9 82+85+86
457 2933 99 opaviraline 178040-94-3 83
458 2934 99 opebacan 206254-79-7 83
459 3002 10 oregovomab 213327-37-8 86
460 2941 90 oritavancin 171099-57-3 83+84
461 2932 99 ortataxel 186348-23-2 87
462 2924 29 oseltamivir 196618-13-0 80
463 2932 99 osemozotan 137275-81-1 87
464 2909 49 ospemifene 128607-22-7 85
465 2933 39 otamixaban 193153-04-7 86
466 2933 69 oteracil 937-13-3 80
467 2932 99 oxeglit azar 280585-34-4 88
468 2941 90 ozogamicin 0-00-0 83+86
469 2932 99 paclitaxel ceribate 186040-50-6 91
470 [2932 99] [3824 
90] [3908 90] paclitaxel poliglumex 263351-82-2 90
471 2933 99 pactimibe 189198-30-9 89
807 2843 90 padoporfin 274679-00-4 93
808 3002 10 pagibaximab 595566-61-3 93
472 2933 29 palifermin 162394-19-6 86+88
474 2934 99 paliperidone 144598-75-4 83+84
809 2933 39 paliroden 188396-77-2 93
475 3002 10 palivizumab 188039-54-5 79
476 2933 49 palosuran 540769-28-6 91
477 3002 10 panitumumab 339177-26-3 91
478 2937 19 parathyroid hormone 345663-45-8 90
479 2935 00 parecoxib 198470-84-7 80
480 3002 10 pascolizumab 331243-22-2 87
481 2933 99 pasireotide 396091-73-9 90
482 2941 90 patupilone 152044-54-7 89
810 2937 19 peforelin 147859-97-0 93
483 3907 20 pegacaristim 187139-68-0 80
484 2939 99    pega motecan 203066-49-3 91
485 3907 20 pegaptanib 0-00-0 87+88
486 3907 20 pegfilgrastim 208265-92-3 85+86
487 3907 20 peginterferon alfa-2a 198153-51-4 84
488 3907 20 peginterferon alfa-2b 215647-85-1 84 
 
Schedule XIV – Norway – Proposed INN list              Page 19   WT/Let/654   ID # HS Code INN Name CAS-RN Propos. INN List
489 3907 20 pegnartograstim 204565-76-4 80
490 3907 20 pegsunercept 330988-75-5 87
491 2937 19 pegvisomant 218620-50-9 82
759 2934 99 peliglit azar 331744-64-0 92
492 2933 49 pelitinib 257933-82-7 91
493 2934 99 pelitrexol 446022-33-9 90
760 2930 90 pemaglit azar 496050-39-6 92
494 2925 20 peramivir 229614-55-5 86
495 2903 30 perflexane 355-42-0 82
761 2903 30 perflisobutane 354-92-7 92
496 2903 47 perflubrodec 307-43-7 87
497 2903 30 perflubutane 355-25-9 91
498 2903 30 perflutren 76-19-7 82
499 3002 10 pertuzumab 380610-27-5 89
500 2933 99 perzinfotel 144912-63-0 91
501 3002 10 pexelizumab 219685-93-5 85+86
502 2934 99 piboserod 152811-62-6 79
503 2933 59 pibrozelesin 154889-68-6 81
762 2934 99 piclozotan 182415-09-4 92
504 2843 90 picoplatin 181630-15-9 87
505 2934 99 pimecrolimus 137071-32-0 81
506 2933 49 pinokalant 149759-26-2 82
507 2933 39 pipendoxifene 198480-55-6 84
508 2933 49 pitavastatin (itavastatin) 147511-69-1 80+83+86
509 2934 99 pitrakinra 0-00-0 84
510 2933 99 pixantrone 144510-96-3 89
811 2933 99 plerixafor 110078-46-1 93
511 2933 59 plevitrexed 153537-73-6 87+89
812 2934 99 plitidepsin 137219-37-5 93
512 2933 69 ponazuril 69004-04-2 80
513 2934 99 posaconazole 171228-49-2 82+85+ 86
514 2934 99 posizolid 252260-02-9 88
813 [2933 59] 
[2934 99] pradefovir 625095-60-5 93
515 2933 49 pradofloxacin 195532-12-8 84
763 2933 59 pralatrexate 146464-95-1 92
516 2934 99 pralnacas an 192755-52-5 85
517 2934 99 prasugrel 150322-43-3 91
518 2933 99 pratosartan 153804-05-8 85
519 2933 39 prazarelix 134457-28-6 81
520 2935 00 prinomastat 192329-42-3 82+86
521 3002 10 pritumumab 499212-74-7 89
779 3504 00 protamine sulfate 9009-65-8 8Schedule XIV – Norway – Proposed INN list               Page 20  WT/Let/654  ID # HS Code INN Name CAS-RN Propos. INN List
522 2933 59 pruvanserin 443144-26-1 90
523 2933 99 pumafentrine 207993-12-2 82+86
524 2934 99 pumosetrag 153062-94-3 87
525 2934 99 radafaxine 192374-14-4 91
543 2934 99 radequinil (resequinil) 219846-31-8 90+93
764 2934 99 radotermin 575458-75-2 92
526 2933 99 rafabegron 244081-42-3 88
527 2934 99 ragaglit azar 222834-30-2 85
528 2924 29 ralfinamide 133865-88-0 89
529 2932 99 ramelteon 196597-26-9 90
530 3002 10 ranibizumab 347396-82-1 90
531 2933 59 ranirestat 147254-64-6 91
532 3507 90 ranpirnase 196488-72-9 81
533 3507 90 rasburicase 134774-45-1 81+82
534 2934 10 ravuconazole 182760-06-1 83
765 3002 10 raxibacumab 565451-13-0 92
535 2934 99 razaxab an 218298-21-6 90
536 2933 29 rebimastat 259188-38-0 89
537 2934 99 regadenoson 313348-27-5 91
538 2934 99 reglit azar 170861-63-9 84
539 2935 00 relcovaptan 150375-75-0 82
540 2935 00 reparixin 266359-83-5 91
541 2933 29 repifermin 219527-63-6 82
542 2935 00 repinotan 144980-29-0 79
544 2933 99 resiquimod 144875-48-9 82
545 3002 10 reslizumab 241473-69-8 85
546 2941 90 retapamulin 224452-66-8 91
547 2933 59 revaprazan 199463-33-7 91
548 2933 59 rilpivirine 500287-72-9 91
814 2934 99 rimacalib 215174-50-8 93
766 2930 90 rimeporide 187870-78-6 92
549 2933 39 rimonabant 168273-06-1 83
550 2934 10 risarestat 79714-31-1 82
551 2922 50 ritobegron 255734-04-4 91
815 2933 39 rivanicline 15585-43-0 93
552 2934 99 rivaroxaban 366789-02-8 90
816 2937 50 rivenprost 256382-08-8 93
553 2934 10 rivoglitazone 185428-18-6 84
554 2922 49 robenacoxib 220991-32-2 91
555 2932 29 rofecoxib 162011-90-7 80
556 2932 19 rostafuroxin 156722-18-8 91
557 2933 99 rostaporfin 284041-10-7 83+84
558 2935 00 rosuvastatin 287714-41-4 83+85+94
559 2934 99 rotigotine 99755-59-6 83 
 
Schedule XIV – Norway – Proposed INN list              Page 21   WT/Let/654   ID # HS Code INN Name CAS-RN Propos. INN List
560 3002 10 rovelizumab 197099-66-4 81
561 2939 99 rubitecan 91421-42-0 82
562 2934 99 ruboxistaurin 169939-94-0 85
563 2934 99 rupintrivir 223537-30-2 88
564 3002 10 ruplizumab 220651-94-5 83
565 2941 90 sabarubicin 211100-13-9 90
566 2933 59 sabiporide 324758-66-9 84+85
567 2924 29 safinamide 133865-89-1 84
568 2924 29 salcaprozic acid 183990-46-7 88
720 2924 29 salclobuzic acid 387825-03-8 92
569 2934 99 sarakalim 148430-28-8 81
570 2928 00 sardomozide 149400-88-4 79
571 2934 99 sarizotan 351862-32-3 80+94
817 2935 00 satavaptan 185913-78-4 93
572 2843 90 satraplatin 129580-63-8 80
767 2933 99 saxagliptin 361442-04-8 92
573 2937 23 segesterone 7690-08-6 89
574 2932 29 selamectin 165108-07-6 81
818 2933 79 seletracet am 357336-74-4 93
768 2933 59 seliciclib 186692-46-6 92
575 2934 99 selodenoson 110299-05-3 91
576 2928 00 semapimod 352513-83-8 89
577 2933 79 semaxanib 194413-58-6 85
578 2933 29 semparatide 154906-40-8 80
579 2933 39 senazodan 98326-32-0 85
580 2934 20 sibenadet 154189-40-9 84
581 3002 10 sibrotuzumab 216669-97-5 81+86
582 2933 99 silodosin 160970-54-7 85
584 3002 10 siplizumab 288392-69-8 87
819 2934 10 sipoglit azar 342026-92-0 93
585 2934 99 siramesine 147817-50-3 81
586 2933 49 sitamaquine 57695-04-2 80
587 2935 00 sitaxentan 184036-34-8 83
588 2933 99 soblidotin 149606-27-9 84
589 2922 50 solabegron 252920-94-8 90
590 2933 49 solifenacin 242478-37-1 85
591 2933 39 solimastat 0-00-0 80
592 2909 50 soneclosan 3380-30-1 84
593 2935 00 sonepiprazole 170858-33-0 80
594 2933 39 sorafenib 284461-73-0 88
595 2933 99 soraprazan  261944-46-1 87+88
596 2922 19 squalamine 148717-90-2 88
597 2933 99 stannsoporfin 106344-20-1 79+86Schedule XIV – Norway – Proposed INN list               Page 22  WT/Let/654  ID # HS Code INN Name CAS-RN Propos. INN List
598 2934 99 sufugolix 308831-61-0 89
769 [2932 99] 
[2938 90] sugammadex 343306-71-8 92
599 2935 00 sulamserod 0-00-0 82
600 2933 99 sumanirole 179386-43-7 84
820 2933 79 sunitinib 557795-19-4 93
821 2933 39 surinabant 288104-79-0 93
601 2924 29 tabimorelin 193079-69-5 80+86
602 2941 90 tacapen em 193811-33-5 87
603 2924 29 tacedina line 112522-64-2 88
604 2934 99 tadalafil 171596-29-5 85
605 2933 29 tadekinig alfa 220712-29-8 90
606 2933 49 tafenoquine 106635-80-7 80
607 2940 00 tafluposide 179067-42-6 85
608 2937 50 tafluprost 209860-87-7 89
770 2933 99 talabostat 149682-77-9 92
771 [2934 99] 
[3002 10] talactoferrin alfa 308240-58-6 92+93
772 2924 29 talaglumetad 441765-98-6 92
609 2934 99 talampanel 161832-65-1 80
610 2933 99 talaporfin 110230-98-3 83+84
611 2922 19 talibegron 146376-58-1 86
612 3002 10 talizumab 380610-22-0 89
613 2933 49 talnetant 174636-32-9 81
614 2924 29 taltobulin 228266-40-8 91
615 2934 99 tanaproget 304853-42-7 90
616 2933 59 tandutinib 387867-13-2 91
617 3002 10 taneptacogin alfa 465540-87-8 90
773 2933 99 tanogitran 637328-69-9 92
618 2930 90 tanomastat 179545-77-8 82+86
619 2922 29 tapentadol 175591-23-8 87+89
620 3002 10 taplitumomab paptox 235428-87-2 84
621 2935 00 taprizosin 210538-44-6 90
622 2933 49 tariquidar 206873-63-4 86
822 2933 99 tasidotin 192658-64-3 93
823 2933 79 tasquinimod 254964-60-8 93
623 2933 39 tebanicline 198283-73-7 86
624 2941 90 tebipenem pivoxil (tebipenem) 161715-24-8 82+87
625 2934 99 tecadenoson 204512-90-3 87
626 2922 29 tecalcet  148717-54-8 87
627 2933 39 tecastemizole 75970-99-9 86
628 2844 40 technetium (99mTc) 
fanolesomab 225239-31-6 86
629 2844 40 technetium (99mTc) nitridocade 131608-78-1 89
630 2937 19 teduglutide 287714-30-1 90
774 3002 10 tefibazumab 521079-87-8 92 
 
Schedule XIV – Norway – Proposed INN list              Page 23   WT/Let/654   ID # HS Code INN Name CAS-RN Propos. INN List
631 2933 99 tegaserod 145158-71-0 79
632 2924 19 teglicar 250694-07-6 91
633 2941 90 telavancin 372151-71-8 91
634 2934 99 telbermin 205887-54-3 85
635 2934 99 telbivudine 3424-98-4 88
636 2941 90 telithromycin 173838-31-8 80
775 2934 99 temsirolimus 162635-04-3 92
637 2933 39 tenatoprazole 113712-98-4 80
638 3507 90 tenecteplase 191588-94-0 79
639 3002 10 teneliximab 299423-37-3 87
640 2918 19 tenivastatin 121009-77-6 85
641 2933 59 tenofovir 147127-20-6 82
642 2926 90 teriflunomide 108605-62-5 80
824 2935 00 terutroban 165538-40-9 93
643 2918 90 tesaglit azar 251565-85-2 85
825 2934 99 tesetaxel 333754-36-2 93
644 2922 19 tesmilifene 98774-23-3 81
645 2933 39 tesofensine 195875-84-4 89
646 2934 10 tetomilast 145739-56-6 91
647 2934 99 tezacitabine 130306-02-4 84
648 2935 00 tezosentan 180384-57-0 81
776 2934 99 thrombomodulin alfa 120313-91-9 92
649 2933 39 ticalopride 202590-69-0 83
650 2932 99 tidembersat 175013-73-7 84
651 2934 99 tifenazoxide 279215-43-9 89
652 2933 99 tifuvirtide 251562-00-2 91
653 2941 30 tigecycline 220620-09-7 86
654 2935 00 tilmacoxib 180200-68-4 84
655 2933 39 timcodar 179033-51-3 80
656 2933 79 tipifarnib 192185-72-1 84+87
657 2933 29 tiplimotide 178823-49-9 82
658 2935 00 tipranavir 174484-41-4 80
659 2918 19 tisocalcitate 156965-06-9 89
660 2933 59 tiviciclovir 103024-93-7 86
661 3002 10 tocilizumab 375823-41-9 90
662 2934 99 tocladesine 41941-56-4 81
663 2934 99 tofimilast 185954-27-2 85
664 3911 90 tolevamer 28210-41-5 88
665 2933 99 tolvaptan 150683-30-0 83
666 2935 00 tomeglovir 233254-24-5 84
667 2932 99 tonabersat 175013-84-0 80+85
668 2924 29 topilutamide 260980-89-0 91
669 2933 99 topixantrone 156090-18-5 87Schedule XIV – Norway – Proposed INN list               Page 24  WT/Let/654  ID # HS Code INN Name CAS-RN Propos. INN List
670 3002 10 toralizumab 252662-47-8 87
671 2934 99 torapsel 204658-47-9 91
672 2933 49 torcetrapib 262352-17-0 87
673 2934 99 torcitabine 40093-94-5 87
674 2937 23 tosagestin 110072-15-6 86
675 3002 10 tositumomab 192391-48-3 80
676 2934 99 trabectedin 114899-77-3 86
677 2918 90 travoprost 157283-68-6 80
678 2933 39 traxoprodil 134234-12-1 84+86
679 2935 00 trecetilide 180918-68-7 79
680 2937 50 treprostinil 81846-19-7 87
826 2933 99 tretazicar 21919-05-1 93
681 2933 99 tridolgosir 72741-87-8 84
682 2843 90 triplatin tetranitrate 172903-00-3 87
683 2922 19 trodusquemine 186139-09-3 91
684 2934 99 troxacitabine 145918-75-8 81
685 2941 90 tulathromycin 217500-96-4 
tulathromycin A + 
280755-12-6 tulath. B 87
827 2935 00 udenafil 268203-93-6 93
686 2934 99 ulifloxacin 112984-60-8 89
687 2937 29 uliprisnil 159811-51-5 90
688 2934 99 upidosin 152735-23-4 80
689 3002 10 urtoxazumab 502496-16-4 90
828 2924 29 valategrast 220847-86-9 93
690 2935 00 valdecoxib 181695-72-7 80
691 2933 59 valomaciclovir 195157-34-7 84
829 2934 99 valopicitabine 640281-90-9 93
692 2924 19 valrocemide 92262-58-3 82
693 2941 90 valrubicin 56124-62-0 79
694 2934 99 valtorcitabine 380886-95-3 90
695 2933 59 vandetanib 338992-00-0 91
696 2842 90 vangatalcite 12539-23-0 80
697 3002 10 vapaliximab 336801-86-6 87
698 2935 00 vardenafil 224785-90-4 82
699 2933 39 varenicline 249296-44-4 89
700 2933 99 varespladib 172732-68-2 87
701 2933 39 vatalanib 212141-54-3 84
702 3002 10 vepalimomab 195158-85-1 80
778 2933 99 verteporfin 129497-78-5 71+91
703 2933 59 vestipitant 334476-46-9 91
704 2934 99 vilazodone 163521-12-8 80+81
705 2933 99 vildagliptin 274901-16-5 90
706 3002 10 visilizumab 219716-33-3 84
707 2933 39 vofopitant 168266-90-8 82 
 
Schedule XIV – Norway – Proposed INN list              Page 25   WT/Let/654   ID # HS Code INN Name CAS-RN Propos. INN List
830 3002 10 volociximab 558480-40-3 93
708 2941 90 volpristin 21102-49-8 80
709 2922 19 xidecaflur 207916-33-4 85
710 2933 99 ximelagatran 192939-46-1 84
711 2844 40 yttrium (90Y) tacatuzumab 
tetraxetan (yttrium (90Y) 
tacatuzumab) 476413-07-7 91+93
831 2933 99 zabofloxacin 219680-11-2 93
832 3002 10 zalutumumab 667901-13-5 93
712 2933 39 zanapezil 142852-50-4 85
713 3002 10 zanolimumab 652153-01-0 90
714 2933 49 zelandopam 139233-53-7 84+86
715 3002 10 ziralimumab 0-00-0 84
716 2933 59 zonampanel 210245-80-0 85
717 2933 49 zoniporide 241800-98-6 85
718 2933 59 zosuquidar 167354-41-8 86
719 2937 22 zoticasone 0-00-0 85+86 
Schedule XIV – Norway – Prefixes and suffixes                                               Page 26                 WT/Let/654 ANNEX II  
Proposed new list of prefixes and suffixes  
Sorted by prioritary prefixes and suffixes ascending  
 
INN = International Nonproprietary Names for pharmac eutical substances, World Health Organization; 
INNRG = International Nonproprietary Names (INN) for pharmaceuti cal substances, Names for radicals & groups, comprehensive list  2004; 
INNCN = chemical or systematic name listed in International N onproprietary Names (INN) for pharm aceutical substa nces, Names for  radicals & groups, 
comp. list 2004. 
 
Add the following note: 
"Prefixes and suffixes can be combined." 
"They can be preceded by a multiplying prefix such as bi, bis,  di, hemi, hepta, hexa, mono, pe nta, sesqui, tetra, tri, tris…" 
"Synonyms and systematic names can also be used, in the same way."  
 
ID 
 Prioritary prefixes and 
suffixes Synonyms 
 Systematic name when different 
 Currently existing combinations and 
multiples 
1 acefurate (INNRG)   acetate (ester), fu ran-2-carboxylate (e ster) (INNCN)   
2 aceglumate (INNRG)   rac-hydrog en N-acetylglutamate (INNCN)   
3 aceponate (INNRG)   acetate (ester),  propanoate (ester) (INNCN)   
4 acetate     diacetate, hexaacetate 
5 acetonide (INNRG)   propane- 2,2-diylbis(oxy) (INNCN)   
6 acetofenide acetophenide 1-phen ylethane-1,1-diylbis(oxy)   
7 1-acetoxyethyl   1- (acetyloxy)ethyl   
8 aceturate (INNRG)   N-acet ylglycinate (INNCN)   
10 acetylsalicylate   2-(acetyloxy)benzoate   
11 acibutate (INNRG)   acetat e (ester), 2-methylpropa noate (ester) (INNCN)   
12 acistrate (INNRG)   acet ate (ester), octadecanoate (ester) (INNCN)   
13 acoxil (INNRG)   (acet yloxy)methyl (INNCN)   
14 adipate   hexanedioate   
15 alfoscerate (INNRG)   (2R)-2,3-dihydroxypropyl hydrogen phosphate (INNCN)    
Schedule XIV – Norway – Prefixes and suffixes                                             Page 27              WT/Let/654 ID 
 Prioritary prefixes and 
suffixes Synonyms 
 Systematic name when different 
 Currently existing combinations and 
multiples 
16 alideximer (INNRG)   poly([oxy(2-hydroxyethane-1,1-diyl)]{oxy[1-
(hydroxymethyl)ethane-1,2-diyl]}) partly O-etherified with 
carboxymethyl groups with some carboxy groups amide 
linked to the tetrapeptide residue (glycylglycyl- 
L-phenylalanylglycyl) (INNCN)   
17 allyl   prop-2-en-1-yl   
18 allylbromide allylobromide N-allyl, bromide (salt)   
19 allyliodide allyloiodide N-allyl, iodide (salt)   
20 aluminium       
21 4-aminosalicylate aminosalicylate 2-hydroxy-4-aminobenzoate   
22 ammonium     diammonium, ammonium fusidate 
24 amsonate (INNRG)   2,2'-ethene-1,2-diylbis(5-aminobenzene-1-sulfonate) 
(INNCN)   
25 anisatil (INNRG)   2-(4-methox yphenyl)-2-oxoethyl (INNCN)   
26 antipyrate       
27 arbamel (INNRG)   2-(dimethylamino)-2-oxoethyl (INNCN)   
28 argine (INNRG)   30B α-L-arginine-30B β-L-arginine (INNCN)   
29 arginine (INN)       
30 aritox (INNRG)   ricin A chain-MAB immunotoxine (INNCN)   
31 ascorbate       
32 aspart (INNRG)   28B-L-aspartic acid- (INNCN)   
33 aspartate       
34 axetil (INNRG)   rac-1-( acetyloxy)ethyl (INNCN)   
35 barbiturate   2,4,6(1H,3H,5H)-pyrimidinetrione   
36 benetonide (INNRG)   N-benzoyl-2-methyl- β-alanine (ester), acetonide (INNCN)   
37 benzathine   N,N'-dibenzylethylenediammonium    
40 benzoacetate       
41 benzoate (INNRG)     monobenzoate, dibenzoate 
42 benzyl        
Schedule XIV – Norway – Prefixes and suffixes                                               Page 28                 WT/Let/654 ID 
 Prioritary prefixes and 
suffixes Synonyms 
 Systematic name when different 
 Currently existing combinations and 
multiples 
43 benzylbromide benzylobromide N-benzyl, bromide (salt)   
44 benzyliodide benzyloiodide N-benzyl, iodide (salt)   
45 besilate (INNRG) besylate benzenesulfonate (INNCN), benzenesulphonate   
47 bezomil (INNRG)   (benzoyloxy)methyl (INNCN)   
53 bismuth       
55 borate       
56 bromide (INNRG)       
57 buciclate (INNRG)   trans-4-buty lcyclohexanecarboxylate (INNCN)   
58 bunapsilate (INNRG)   3,7-di-tert-butylnaphthalene-1,5-disulfonate (INNCN)   
59 buteprate (INNRG)   butyrate (ester), propionate (ester) (INNCN)   
60 butyl       
62 tert-butyl t-butyl, tertiary butyl     
67 butyl ester       
69 tert-butyl ester t-butyl ester, tertiary 
butyl ester     
75 butylbromide butylobromide N-butyl, bromide (salt)   
76 butyrate butylate butanoate dibutyrate 
77 calcium     calcium di hydrate, calcium chloride 
82 camphorate   1,2,2-trimethyl-1,3-cyclopentanedicarboxylate   
85 camsilate (INNRG) camsylate, 
camphorsulfonate, 
camphorsulphonate, R-
camphorsulfonate, R-
camphorsulphonate, S-
camphorsulfonate, S-
camphorsulphonate, 
camphor-10-sulfonate, 
camphor-10-sulphonate (7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-
yl)methanesulfonate (INNCN)   
87 caproate (INNRG)   hexanoate (INNCN)    
Schedule XIV – Norway – Prefixes and suffixes                                             Page 29              WT/Let/654 ID 
 Prioritary prefixes and 
suffixes Synonyms 
 Systematic name when different 
 Currently existing combinations and 
multiples 
88 carbamate       
89 carbesilate (INNRG)   4-sulfobenzoate (INNCN)   
90 carbonate       
91 chloride (INNRG)     calcium chloride 
95 choline   (2-hydroxyethyl)trimethylammonium dicholine 
96 ciclotate (INNRG) cyclotate 4-methylbicyclo[2.2.2]oct-2-ene-1-carboxylate (INNCN)   
97 cilexetil (INNRG)   rac-1-{[(cyclohe xyloxy)carbonyl]oxy}ethyl (INNCN)   
98 cinnamate   3-phenylprop-2-enoate   
99 cipionate (INNRG) cypionate, 
cyclopentanepropionate 3-cyclopentylpropanoate (INNCN), 3-
cyclopentylpropionate   
100 citrate   2-hydroxypropane-1,2,3-tricarboxylate dihydrogen citrate, ferrous citrate 
101 cituxetan (INNRG)   N-(4-{2(RS)-2-[bis(carboxymethyl)amino)]-3-({2-
[bis(carboxymethyl)=amino]ethyl}(carboxymethyl)amino)p
ropyl}phenyl)thiocarbamoyl (INNCN)   
102 clofibrol (INNRG)   2-(4-chlorophenoxy)-2-methylpropyl (INNCN)   
103 closilate (INNRG) closylate, p-
chlorobenzenesulfonate, 
p-
chlorobenzenesulphonat
e 4-chlorobenzene-1-sulfonate (INNCN), 4-
chlorobenzenesulfonate   
105 crobefate (INNRG)   rac-{3-[(3E)-4-methoxybenzylidene]-2-(4-
methoxyphenyl)chroman- 
6-yl phosphate(2-)} (INNCN)   
106 cromacate (INNRG)   2-[(6-hydroxy -4-methyl-2-ox o-2H-chromen-
7yl)oxy]acetate (INNCN)   
107 cromesilate (INNRG)   (6,7-dihydroxy-2-oxo-2H-chromen-4-yl)methanesulfonate 
(INNCN)   
108 crosfumaril (INNRG)   (2E)-but-2-enedioyl (INNCN)   
109 cyclamate (INNRG) N- cyclohexylsulfamate, 
N-
cyclohexylsulphamate cyclohexylsulfamate (INNCN)    
Schedule XIV – Norway – Prefixes and suffixes                                               Page 30                 WT/Let/654 ID 
 Prioritary prefixes and 
suffixes Synonyms 
 Systematic name when different 
 Currently existing combinations and 
multiples 
110a cyclohexylamine       
111 cyclohexylammonium       
112 cyclohexylpropionate cyclohexanepropionate cyclohexylpropanoate   
118 daloxate (INNRG)   L-alaninate (ester), (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 
(INNCN)   
120 daropate (INNRG) dapropate 3-(dimethylamino)propanoate (INNCN)   
121 deanil (INNRG)   2-(dimethylamino)ethyl (INNCN)   
122 decanoate       
123 decil (INNRG)   decyl (INNCN)   
124 defalan (INNRG)   des-1B-L-phenylalanine-insulin (INNCN)   
125 detemir (INNRG)   tetradecanoyl (INNCN)   
129 dibudinate (INNRG)   2,6-di-tert-butylnaphthalene-1,5-disulfonate (INNCN)   
130 dibunate (INNRG)   2,6-di-tert-butylnaphthalene-1-sulfonate (INNCN)   
133 dicibate (INNRG)   dicyclohexylmethyl carbonate (INNCN)   
134 dicyclohexylamine       
135 dicyclohexylammonium       
137 diethylamine       
138 diethylammonium       
139 diftitox (INNRG)   N-L-methionyl- 387-L-histidine-388-L-alanine-1-388-toxin 
(Corynebacterium diphtheriae strain C7) (388 →2')-protein 
(INNCN)   
142 digolil (INNRG)   2-(2-hydroxyethoxy)ethyl (INNCN)   
149 dihydroxybenzoate       
154 N,N-dimethyl- β-alanine N, N-dimethyl-beta-
alanine     
156 dinitrobenzoate       
157 diolamine (INNRG) diethanolamine 2,2’-azanediyldieth anol (INNCN)   
165 disulfide disulphide      
Schedule XIV – Norway – Prefixes and suffixes                                             Page 31              WT/Let/654 ID 
 Prioritary prefixes and 
suffixes Synonyms 
 Systematic name when different 
 Currently existing combinations and 
multiples 
169 docosil (INNRG)   docosyl (INNCN)   
170 dofosfate (INNRG)   octadecyl hydrogen phosphate (INNCN)   
171 ecamate (INNRG)   N-ethylcarbamate (INNCN)   
172 edamine (INNRG)   ethane-1,2-diamine (INNCN)   
173 edisilate (INNRG) edisylate, 1,2-
ethanedisulfonate, 1,2-
ethanedisulphonate ethane-1,2-disulfonate (INNCN) hydrogen edisilate 
175 embonate (INNRG) pamoate, 4,4'-
methylenebis(3-
hydroxy-2-naphthoate) 4,4'-methylenebis(3-hydroxynaphthalene-2-carboxylate) 
(INNCN)   
176 enantate (INNRG) enanth ate heptanoate (INNCN)   
178 enbutate (INNRG)   acetate (est er), butanoate (ester) (INNCN)   
179 epolamine (INNRG) 1-pyrrolidineethanol 2-(pyrrolidin-1-yl)ethanol (INNCN)   
180 erbumine (INNRG) tert-butylamine, t-
butylamine, tertiary 
butylamine 2-methylpropan-2-amine (INNCN)   
181 esilate (INNRG) esylate, ethanesulfonate, 
ethanesulphonate ethanesulfonate (INNCN)   
182 estolate (INNRG) propionate dodecyl 
sulfate, propionate 
dodecyl sulphate, 
propionate lauryl 
sulfate, propionate 
lauryl sulphate propanoate (ester), dodecyl sulfate (salt) (INNCN)   
184 etabonate (INNRG)   ethyl carbonate (INNCN)   
190 ethylbromide ethobromide N-ethyl, bromide (salt)   
191 ethyl       
192 ethyl ester       
193 ethylamine       
194 ethylammonium        
Schedule XIV – Norway – Prefixes and suffixes                                               Page 32                 WT/Let/654 ID 
 Prioritary prefixes and 
suffixes Synonyms 
 Systematic name when different 
 Currently existing combinations and 
multiples 
195 ethylenantate ethylheptanoate     
196 ethylenediamine   ethane-1,2-diamine   
197 ethylhexanoate       
198 ethyliodide ethyloiodide N-ethyl, iodide (salt)   
199 ethylsuccinate       
200 etilsulfate (INNRG) ethylsulfate ethyl sulfate (INNCN)   
201 farnesil (INNRG)   (2E ,6E)-3,7,11-trimet hyldodeca-2,6,10-trien-1-yl (INNCN)   
202 fendizoate (INNRG)   2-(6-hydroxybiphenyl-3-carbonyl)benzoate (INNCN)   
203a ferrous     ferrous citrate 
204 fluoride       
205 fluorosulfonate fluorosulphonate     
207 formate       
209 fosfatex       
210 fostedate (INNRG)   tetradecy l hydrogen phosphate (INNCN)   
211 fumarate   (2E)-but-2-enedioate difumarate, hydrogen fumarate 
212 furetonide (INNRG)   1-benzofurane-2-carboxylate (ester), propane-2,2-
diylbis(oxy) (INNCN)   
213 furoate   furan-2(or  3)-carboxylate difuroate 
213a fusidate     ammonium fusidate 
214 gadolinium       
215 gamolenate (INNRG)   (6Z,9Z,12Z)-octadeca-6,9, 12-trienoate (INNCN)   
216 glargine (INNRG)   21A-glycine-30B α-L-arginine-30B β-L-arginine (INNCN)   
217 glucarate saccharate (2 R,3S,4S,5S)- 2,3,4,5-tetrahydro xyhexanedioate, D-
glucarate   
218 gluceptate (INNRG) glucoheptonate D-glycero-D-gulo-heptonate (INNCN)   
220 gluconate       
221 glucoside       
222 glulisine (INNRG)   3B-L-lysine,29B-L-glutamic acid (INNCN)    
Schedule XIV – Norway – Prefixes and suffixes                                             Page 33              WT/Let/654 ID 
 Prioritary prefixes and 
suffixes Synonyms 
 Systematic name when different 
 Currently existing combinations and 
multiples 
223 glutamer (INNRG)   glutaraldehyde polymer (INNCN)   
224 glycolate   hydroxyacetate   
225 glyoxylate   oxoacetate   
226 gold       
227 guacil (INNRG)   2-methoxyphenyl (INNCN)   
228 guanidine       
230 hemisuccinate (INNRG) hydrogen succinate hydrogen butanedioate (INNCN)   
235 hexacetonide (INNRG)   3,3-dimethylbutanoate (ester ), propan-2,2 -diylbis(oxy) 
(INNCN)   
238 hibenzate (INNRG) hybenzate 4-(4-hydroxybenzoyl)benzoate (INNCN)   
239 hippurate   N-Benzoylglycine salt   
241 hyclate (INNRG)   ethanol – hydrogen chloride - water (0,5/1/0,5) (INNCN)   
242 hydrate     hemihydrate, monohydrate, dihydrate, 
trihydrate, tetrahydr ate, pentahydrate, 
hexahydrate, calcium dihydrate, 
hydrochloride dihydrate, hydrochloride 
hemihydrate, hydrochloride 
monohydrate, sodium hydrate, sodium 
monohydrate, heptahydrate, 
sesquihydrate 
243 hydrobromide     dihydrobromide 
244 hydrochloride     monohydrochloride, dihydrochloride, 
hydrochloride dihydrate, hydrochloride 
hemihydrate, hydrochloride 
monohydrate, palmitate hydrochloride, 
hydrochloride phosphate, 
dihydrochloride phosphate, pivoxil 
hydrochloride, N-oxide hydrochloride  
Schedule XIV – Norway – Prefixes and suffixes                                               Page 34                 WT/Let/654 ID 
 Prioritary prefixes and 
suffixes Synonyms 
 Systematic name when different 
 Currently existing combinations and 
multiples 
248a hydrogen     hydrogen edisilate, hydrogen fumarate, 
hydrogen malate, bis(hydrogen malate), 
hydrogen maleate, bis(hydrogen 
maleate), hydrogen malonate, 
bis(hydrogen malonate), hydrogen 
oxalate, hydrogen sulfate, hydrogen 
sulfite, hydrogen sulphate, hydrogen 
sulphite, hydrogen tartrate, sodium 
hydrogen phosphate, dihydrogen citrate, 
dihydrogen phosphate 
261 hydroxide       
262 hydroxybenzoate       
263 2-(4-
hydroxybenzoyl)benzoate o-(4-
hydroxybenzoyl)benzoa
te     
267 hydroxynaphtoate (INNRG) hydroxynaphthoate 3-hydroxynaphthalene-2-carboxylate (INNCN)   
268 iodide (INNRG)     triiodide 
269 iodine-131       
270 iron chloride       
272 isetionate (INNRG) isethionate, 2-
hydroxyethansulfonate, 
2-
hydroxyethansulphonate2-hydroxyethane-1-sulfonate (INNCN)   
273 isobutyrate   2-methylpropanoate   
274 isocaproate   4-methylpentanoate   
275 isonicotinate   pyridine-4-carboxylate   
276 isophthalate   benzene-1,3-dicarboxylate   
277 isoproprionate       
278 isopropyl   propan-2-yl tetraisopropyl 
279 lactate   2-hydroxypropanoate    
Schedule XIV – Norway – Prefixes and suffixes                                             Page 35              WT/Let/654 ID 
 Prioritary prefixes and 
suffixes Synonyms 
 Systematic name when different 
 Currently existing combinations and 
multiples 
280 lactobionate   4-O-( β-D-galactopyranosyl)-D-gluconate   
281 laurate (INNRG)   dodecanoate (INNCN)   
282 lauril (INNRG) lauryl dodecyl (INNCN)   
283 laurilsulfate (INNRG) lauril sulfate, lauril 
sulphate, lauryl sulfate, 
lauryl sulphate, 
laurilsulphate, 
laurylsulfate, 
laurylsulphate dodecyl sulfate (INNCN) sodium lauril sulfate, sodium lauril 
sulphate, sodium lauryl sulfate, sodium 
lauryl sulphate 
288 levulinate   4-oxopentanoate   
289 lisetil (INNRG)   L-lysinate (e ster), diethyl (ester) (INNCN)   
290 lisicol (INNRG)   {N-[(5S)-5-carboxy-5-(3 α,7α,12α-trihydroxy-5 β-cholan-
24-amido)pentyl]carbamothioyl}amino (INNCN)   
291 lispro (INNRG)   28B-L-lysine-29B-L-proline (INNCN)   
292 lithium       
293 lutetium       
294 lysinate lysine (INN)     
296 mafenatox (INNRG)   enterotoxin A (227-alanine) (Staphylococcus aureus) 
(INNCN)   
297 magnesium       
298 malate   hydroxybutanedioate  dimalate, hydrogen malate, 
bis(hydrogen malate) 
299 maleate   (Z)-but-2-enoate dimaleate, hydrogen maleate, 
bis(hydrogen maleate) 
300 malonate   propanedioate dimalonate, hydrogen malonate, 
bis(hydrogen malonate) 
301 mandelate   2-hydroxy-2-phenylacetate, α-hydroxybenzeneacetate   
302 medoxomil (INNRG)   (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl (INNCN)   
303 megallate (INNRG)   3,4,5-trimethoxybenzoate (INNCN)   
304 meglumine (INN) N-methylglucamine 1-deoxy-1-methylamino-D-glucitol    
Schedule XIV – Norway – Prefixes and suffixes                                               Page 36                 WT/Let/654 ID 
 Prioritary prefixes and 
suffixes Synonyms 
 Systematic name when different 
 Currently existing combinations and 
multiples 
305 merpentan (INNRG)   {N, N’-[1-(3-oxopropyl)ethane-1,2-diyl]bis(2-
sulfanylacetamidat o)}(4-) (INNCN)   
306 mertansine (INNRG)   tetrakis{(4RS)-4[(3-{[(1S)-2-
{[(1S,2R,3S,5S,6S,16E,18E,20R,21S)-11-chloro-21-
hydroxy-12,20-dime thoxy-2,5,9,16-tetr amethyl-8,23-dioxo-
4,24-dioxa-9,22-
diazatetracyclo[19.3.1.1 10,14.03,5]hexacosa-
10,12,14(26),16,18-pentaen-6-yl]oxy}-1-methyl-2-
oxoethyl]methylamino}-3-oxopropyl)disulfanyl]pentanoyl} 
(INNCN)   
307 mesilate (INNRG) mesylate, 
methanesulfonate, 
methanesulphonate methanesulfonate (INNCN) dimesilate, sodium methanesulfonate, 
sodium methanesulphonate 
309 metembonate (INNRG)   4,4'-methylenebis(3-methoxynaphthalene-2-carboxylate) 
(INNCN)   
312 methonitrate (INNRG)   N-meth yl, nitrate (salt) (INNCN)   
313 methyl ester       
315 methylbromide (INNRG) methobromide N-methyl, bromide (salt) (INNCN)   
317 methylenedisalicylate   meth ylenebis(2-hydroxybenzoate)   
322 metilsulfate (INNRG) metilsulphate, 
methylsulfate, 
methylsulphate methyl sulfate (INNCN)   
324 metiodide (INNRG) methyliodide N-methyl, iodide (salt) (INNCN)   
325 mofetil (INNRG)   2-(morpholin-4-yl)ethyl (INNCN)   
330 mucate galactarate, meso-
galactarate 2,3,4,5-tetrahydroxyhexane-1,6-dioate   
331 nafate formate sodium formyloxy (ester), sodium (salt)   
332 napadisilate (INNRG) napadisylate, 1,5-
naphthalenedisulfonate, 
1,5-
naphthalenedisulphonat
e naphthalene-1,5-disulfonate (INNCN)    
Schedule XIV – Norway – Prefixes and suffixes                                             Page 37              WT/Let/654 ID 
 Prioritary prefixes and 
suffixes Synonyms 
 Systematic name when different 
 Currently existing combinations and 
multiples 
338 napsilate (INNRG) napsylate, 2-
naphthalenesulfonate, 2-
naphthalenesulphonate naphthalene-2-sulfonate (INNCN)   
340 nicotinate (INNRG)   pyridine-3-carboxylate (INNCN)   
341 nitrate     mononitrate, dinitrate, trinitrate 
342 nitrobenzoate       
343 octil (INNRG)   octyl (INNCN)   
344 olamine (INNRG) ethanolamine 2-aminoethanol (INNCN)   
345 oleate (INNRG)   (9Z)-o ctadec-9-enoate (INNCN)   
346 orotate   1,2,3,6-tetrahydro-2,6-dioxopyrimidine-4-carboxylate   
348 oxalate     hydrogen oxalate 
349 oxide     dioxide, N-oxide hydrochloride 
351 oxoglurate (INNRG)   hydrogen 2-oxopentanedioate (INNCN)   
353 palmitate (INNRG)   hexadecanoate (INNCN) tripalmitate, palmitate hydrochloride 
356 pantothenate   N-(2,4-dihydroxy-3,3-dimethyl-1-oxobutyl)- β-alaninate pantothenate sulfate, pantothenate 
sulphate 
359 pegol (INNRG)   α-(2-carboxyethyl)- ω-methoxypoly(oxyethane-1,2-diyl) 
(INNCN)   
360 pendetide (INN)       
362 pentexil (INNRG) pivetil (RS)-1-[(2,2-dimethylpropanoyl)oxy]ethyl (INNCN)   
363 perchlorate (INNRG)       
364 phenylpropionate       
365 phosphate orthophosphate   bis(phosphate), diphosphate, 
hydrochloride phosphate, 
dihydrochloride phosphate, sodium 
hydrogen phosphate, sodium phosphate, 
dihydrogen phosphate, disodium 
phosphate 
366 phosphite       
367 phthalate   benzene-1,2-dicarboxylate    
Schedule XIV – Norway – Prefixes and suffixes                                               Page 38                 WT/Let/654 ID 
 Prioritary prefixes and 
suffixes Synonyms 
 Systematic name when different 
 Currently existing combinations and 
multiples 
368 picrate   2,4,6-trinitrobenzene-1-olate   
369 pivalate (INNRG) trimethylacetate 2, 2-dimethylpropanoate (ester) (INNCN)   
371 pivoxetil (INNRG)   rac- 1-[(2-methoxy-2-met hylpropanoyl)oxy]eth yl (INNCN)   
372 pivoxil (INNRG) (pivaloyloxy)methyl [(2,2-dimethylpropanoyl)oxy]methyl (INNCN) dipivoxil, pivoxil hydrochloride 
374 poliglumex (INNRG)   [poly(L-glutamic acid)z ―(L-glutamate- γ-ester)―poly(L-
glutamic acid)y]n (INNCN)   
375 potassium (INNRG)   potassium (INNCN) potassium sulfate, potassium sulphate 
378 propionate   propanoate dipropionate 
383 propyl       
384 propyl ester       
385 proxetil (INNRG)   rac-1-{[(propan- 2-yloxy)carbonyl]oxy}ethyl (INNCN)   
386 pyridylacetate   pyridinylacetate   
388 quinate   1,3,4,5-tetrahydro xycyclohexanecarboxy late biquinate 
389 raffimer (INNRG)   (2S,4R,6R,8S,11S,13S)-2,4,8,13-tetrakis(hydroxymethyl)-
4,6,11-tris(ylomet hyl)-3,5,7,10,12-pe ntaoxatetradecane-
1,14-diyl (INNCN)   
390 resinate abietate (1R,4aR,4bR,10aR)-1,4a-dimethyl-7-(1-methylethyl)-
1,2,3,4,4a,4b,5,6,10,10a-decahydro-1-
phenanthrenecarboxylate   
392 salicylate (INNRG)   2-hydroxybenzoate (INNCN)   
393 salicyloylacetate   2-hydroxybenzoylacetate   
394 sesquioleate (INNRG)   (9Z)-o ctadec-9-enoate(1, 5) (INNCN)    
Schedule XIV – Norway – Prefixes and suffixes                                             Page 39              WT/Let/654 ID 
 Prioritary prefixes and 
suffixes Synonyms 
 Systematic name when different 
 Currently existing combinations and 
multiples 
395 sodium (INNRG)     disodium, tetrasodium, sodium hydrate, 
sodium monohydrate, sodium sulfate, 
sodium sulphate, sodium lauril sulfate, 
sodium lauril sulphate, sodium lauryl 
sulfate, sodium lauryl sulphate, sodium 
methanesulfonate, sodium 
methanesulphonate, sodium 3-
sulfobenzoate, sodium 3-
sulphobenzoate, sodium hydrogen 
phosphate, sodium phosphate, sodium 
succinate, sodium sulfobenzoate, 
sodium sulphobenzoate, disodium 
phosphate 
413 soproxil (INNRG)   {[(propan-2-yloxy)carbonyl]oxy}methyl (INNCN) disoproxil 
414 steaglate (INNRG)   2-(octad ecanoyloxy)acetate (ester) (INNCN)   
415 stearate (INNRG)   oc tadecanoate (INNCN)   
416 stinoprate (INNRG)   N-acetylcysteinate  (salt), propanoate (ester) (INNCN)   
417 succinate   butanedioate sodium succinate 
418 succinil (INNRG)   3-carboxypropanoyl (INNCN)   
419 succinyl   butanedioyl   
420 sudotox (INNRG)   248-L-histidine-249-L-methionine-250-L-alanine-251-L-
glutamic acid-248-613-exotoxin A (Pseudomonas 
aeruginosa reduced) (INNCN)   
421 suleptanate (INNRG)   8-[methyl(2-sulfoethyl)amino]-8-oxooctanoate (ester), 
monosodium salt (INNCN)   
422 sulfate (INNRG) sulphate   hemisulfate, hemisulphate, disulfate, 
disulphate, potassium sulfate, potassium 
sulphate, sodium sulfate, sodium 
sulphate, hydrogen sulfate, hydrogen 
sulphate, pantothenate sulfate, 
pantothenate sulphate 
423 sulfinate sulphinate     
424 sulfite sulphite   hydrogen sulfite, hydrogen sulphite  
Schedule XIV – Norway – Prefixes and suffixes                                               Page 40                 WT/Let/654 ID 
 Prioritary prefixes and 
suffixes Synonyms 
 Systematic name when different 
 Currently existing combinations and 
multiples 
424a sulfobenzoate sulphobenzoate   sodium sulfobenzoate, sodium 
sulphobenzoate 
424b 3-sulfobenzoate 3-sulphobenzoate   sodium 3-sulfobenzoate, sodium 3-
sulphobenzoate 
425 sulfosalicylate sulphosalicylate 2-hydroxysulfobenzoate   
426 sulfoxylate (INNRG)   sulfinomethyl, monosodium salt (INNCN)   
431 tafenatox (INNRG)   enterotoxin A (Staphyloccus aureus) (INNCN)   
432 tannate       
433 tartrate (INNRG) L-tartrate (2R, 3R)-2,3-dihydroxybuta nedioate (INNCN), L-tartarate bitartrate, hydrogen tartrate 
434 D-tartrate   (2S,3S)-2,3-dihydroxybutanedioate, D-tartarate   
435 tebutate (INNRG) tert -butylacetate, t-butyl 
acetate, tertiary butyl 
acetate 3,3-dimethylbutanoate (INNCN)   
436 tenoate (INNRG)   thiophene-2-carboxylate (INNCN)   
437 teoclate (INNRG) theoclate, 8-
chlorotheophyllinate 8-chloro-1,3-dimethyl-2,6-dioxo-3,6-dihydro-1H-purin-7-
(2H)-ide (INNCN)   
438 teprosilate (INNRG)   3-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-
yl)propane-1-sulfonate (INNCN)   
441 tetrahydrophthalate   cyclohexene-1,2-dicarboxylate   
444 tetraxetan (INNRG)   [4,7,10-tris(carboxymethyl )-1,4,7,10-tetraazacyclodec-1-
yl]acetyl (INNCN)   
446 thiocyanate       
447 tidoxil (INNRG)   rac-2-(decyloxy)-3-(dodecylsulfanyl)propyl (INNCN)   
448 tiuxetan (INNRG)   N-(4-{(2S)-2-[bis(carboxymethyl)amino]-3-[(2RS)-{2-
[bis(carboxymethyl)amino]propyl}(carboxymethyl)amino]p
ropyl}phenyl) thiocarbamoyl (INNCN)   
449 tocoferil (INNRG)   rac-(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-
trimethyltridecyl]chroman-6-yl (INNCN)   
450 tofesilate (INNRG)   3-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-
yl)ethane-1-sulfonate (INNCN)    
Schedule XIV – Norway – Prefixes and suffixes                                             Page 41              WT/Let/654 ID 
 Prioritary prefixes and 
suffixes Synonyms 
 Systematic name when different 
 Currently existing combinations and 
multiples 
453 tosilate (INNRG) tosylate, p-
toluenesulfonate, p-
toluenesulphonate 4-methylbenzene-1-sulfonate (INNCN)   
455 triclofenate (INNRG)   2,4,5-trichlorophenolate (INNCN)   
458 triflutate (INNRG)   trifluoroacetate (INNCN)   
463 trioleate (INNRG)   tris[( 9Z)-octadec-9-enoate] (INNCN)   
465 tristearate (INNRG)   tr is(octadecanoate) (INNCN)   
466 trolamine (INNRG) triethanolamine 2,2’,2’’-nitrilotriethanol (INNCN)   
467 trometamol (INN) tromethamine 2-amino-2-(hydroxymethyl)propane-1,3-diol, 
tris(hydroxymethyl)methylamine   
469 troxundate (INNRG)   [2-(2-etho xyethoxy)ethoxy]acet ate (INNCN)   
472 undecylate (INNRG)   undecanoate (INNCN) diundecanoate 
473 undecylenate (INNRG)   undec-10-enoate (INNCN)   
474 valerate (INNRG)   pentanoate (INNCN)   
475 xinafoate (INNRG)   1-hydroxynaphthalene-2-carboxylate (INNCN)   
476 zinc       
  
Schedule XIV – Norway – Chemical Intermediates                                        Page 42              WT/Let/654 ANNEX III  
Proposed Chemical  Intermediates  
Sorted by HS code and CAS-RN ascending 
Names for accepted intermediates follow IUPAC nomenclature, when relevant 
 
ID # HS code CAS-RN Preferred name 
793 2902 19 6746-94-7 ethynylcyclopropane 
397 2905 29 173200-56-1 (E)-6,6-dimethylhept-2-en-4-yn-1-ol 
250 2905 59 60827-45-4 (2S)-3-chloropropane-1,2-diol 
320 2906 29 127852-28-2 (1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethan-1-ol 
308 2906 29 167155-76-2 1,1-difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c][7]annulen-6-ol 
530A 2909 30 3259-03-8 1-(2-bromoethoxy)-2-ethoxybenzene   or   2-bromoethyl 2-ethoxyphenyl ether 
3 2909 30 165254-21-7 1,2-bi s{2-[2-(2-methoxyethoxy)etho xy]ethoxy}-4,5-d initrobenzene 
124 2909 49 170277-77-7 (3S)-3-[2-(mesyloxy)ethoxy]-4-(trityloxy)butyl methanesulfonate 
636 2913 00 80565-30-6 4'-chlorobiphenyl-4-carbaldehyde 
17 2914 50 4495-66-3 1-[4-(benzyloxy)phenyl]propan-1-one 
566 2914 50 17720-60-4 1-(2,4-dihydroxyphenyl)-2-(4-hydroxyphenyl)ethan-1-one 
316 2914 50 82499-20-5 (1R)-1 -hydroxy-1-(3 -hydroxyphenyl)acetone 
863 2914 70 2196-99-8 2-chloro-1-(4-methoxyphenyl)ethan-1-one 
314 2914 70 2350-46-1 1-(2,3-dichloro-4-hydroxyphenyl)butan-1-one 
827 2914 70 26771-69-7 2-methoxy-1-[4-(trifluoromethyl)phenyl]ethan-1-one 
550 2914 70 43229-01-2 1-[4-(benzyloxy)-3-nitrophenyl]-2-bromoethan-1-one 
64 2914 70 62932-94-9 2-bromo-1-[4-hydroxy-3-(hydroxymethyl)phenyl]ethan-1-one 
712 2914 70 124379-29-9 (4S)-4-(3,4-dichlorophenyl)-3,4-dihydronaphthalen-1(2H)-one 
43 2914 70 135306-45-5 1-(3,5-difluorophenyl)propan-1-one 
59 2914 70 162548-73-4 4,6-difluoroindan-1-one 
158 2914 70 190965-45-8 (2-bromo-5-propoxyphenyl)(2-hydroxy-4-methoxyphenyl)methanone 
755 2915 39 2243-35-8 2- oxo-2-phenylethyl acetate 
519 2915 39 60176-77-4 (1S,4R)-4- hydroxycyclopent-2-en-1-yl acetate 
418 2915 50 158894-67-8 1-bromo-2-methylpropyl propionate 
796 2915 90 7693-41-6 4-methoxyphenyl chloroformate 
686 2916 20 122665-97-8 4,4-difluorocyclohexane-1-carboxylic acid 
869 2916 39 1716-12-7 sodium 4-phenylbutanoate  
Schedule XIV – Norway – Chemical Intermediates                                      Page 43                WT/Let/654 ID # HS code CAS-RN Preferred name 
444 2916 39 2444-36-2 (2-chlorophenyl)acetic acid 
394 2916 39 2901-13-5 ethyl 2-methyl-2-phenylpropanoate 
937 2916 39 114772-40-6 tert-butyl 4’-(bromomethyl)biphenyl-2-carboxylate 
760 2918 19 138-59-0 (3R,4S,5R)-3,4,5-trihydroxycyclohex-1-ene-1-carboxylic acid 
545 2918 19 4335-77-7 cyclohexyl(hydroxy)phenylacetic acid 
544 2918 19 20585-34-6 (2S)-cyclohexyl(hydroxy)phenylacetic acid 
445 2918 19 52950-18-2 (2R)-(2-chlorophenyl)hydroxyacetic acid 
67 2918 19 111969-64-3 (1R,2S ,5R)-2-isopropyl-5-methylcycl ohexyl dihydroxyacetate   or    thymol glyoxylate 
21 2918 30 39562-16-8 ethyl (E)-2-(3-nitrobenzylidene)-3-oxobutanoate 
20 2918 30 39562-22-6 2-methoxyethyl (E)-2-(3-nitrobenzylidene)-3-oxobutanoate 
23 2918 30 39562-27-1 methyl (2E)-2-(2-nitrobenzylidene)-3-oxobutanoate 
508 2918 30 134176-18-4 ethyl 2-oxobicyclo[3.1.0]hexane-6-carboxylate 
214 2918 30 149437-76-3 5-(4-fluorophenyl)-5-oxopentanoic acid 
315 2918 90 1217-67-0 (4-butyryl-2,3-dichlorophenoxy)acetic acid 
108 2918 90 13335-71-2 (2,6-dimethylphenoxy)acetic acid 
532 2918 90 150726-89-9 dimethyl (2-methoxyphenoxy)malonate 
402 2918 90 204254-96-6 ethyl (1S,5R,6S)-5-(1-ethylpropoxy)-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylate 
726 2920 90 80841-78-7 4-(chloromethyl)-5-methyl-1,3-dioxol-2-one 
436 2920 90 163133-43-5   4-(nitrooxy)butyl (2S)-2-(6-methoxy-2-naphthyl)propanoate 
756 2921 49 3789-59-1 (1S)-1-phenylpropan-1-amine 
558 2921 49 84467-54-9 1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutan-1-amine 
540 2921 49 259729-93-6 (1R)-1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutan-1-amine D-tartarate (1:1) 
559 2921 49 389056-74-0 (1S)-1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutan-1-amine D-tartarate (1:1) 
480 2921 59 140-28-3 N,N'-diben zylethane-1,2-diamine diacetate 
42 2922 19 35320-23-1 (2R)-2-aminopropan-1-ol 
512 2922 19 42142-52-9 3-(methylamino)-1-phenylpropan-1-ol 
547 2922 19 56796-66-8 4-(benzyloxy)- α1-[(tert-butylamino)methyl]benzene-1,3-dimethanol 
575 2922 19 58997-87-8 2-(dimethylamino)-2-phenylbutan-1-ol 
226 2922 19 114247-09-5 (3R)-N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine hydrochloride 
84 2922 19 115287-37-1 N-methyl-N-(4-nitrophenethyl)-2-(4-nitrophenoxy) ethan-1-amine 
389 2922 19 168960-19-8 ((1S,4R)-4-aminocyclopent-2-en-1-yl)methanol hydrochloride 
669 2922 19 214353-17-0 1-(2-amino-5-chlorophenyl)-2,2,2-trifluoroethane-1,1-diol hydrochloride  
Schedule XIV – Norway – Chemical Intermediates                                        Page 44              WT/Let/654 ID # HS code CAS-RN Preferred name 
670 2922 19 467426-34-2 (2S)-2-(2-amino-5-chlorophenyl)-4-cyclopropyl-1,1,1-trifluorobut-3-yn-2-ol methanesulfonate (1:1.5) 
85 2922 29 115256-13-8 4-(1-{[2-(4-aminophenoxy)ethyl]methylamino}ethyl)aniline 
552 2922 29 188690-84-8 (2S)-hydroxy(phenyl)acetic acid — (2R)-N-benzyl-1-(4-methoxyphenyl)propan-2-amine (1:1) (salt) 
745 2922 29 202197-26-0 3-chloro-4-[(3-fluorobenzyl)oxy]aniline 
471 2922 39 14189-82-3 (2E)-3-(N-methylanilino)acrylaldehyde 
486 2922 49 26774-89-0 sodium 2-(c yclohexa-1,4-dien-1-yl)- 2-[((E)-1-methoxy-1-oxobut- 2-en-2-yl)amino]acetate 
231 2922 49 209216-09-1 2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid hydrate 
857 2922 49 223445-75-8 [(3S,4S)-1-(aminomethyl)-3,4-dimethylcyclopentyl]acetic acid 
548 2922 50 50293-90-8 4-[(1R)-2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol hydrochloride 
860 2922 50 62023-62-5 (2S,3S)-3-amino-2-hydroxy-4-phenylbutanoic acid 
945 2922 50 71786-67-9 2-[benzyl(methyl)amino]-1-(3-hydroxyphenyl)ethan-1-one hydrochloride 
18 2922 50 96072-82-1 1-[4-(benzyloxy)phenyl]-2-[(4-phenylbutan-2-yl)amino]propan-1-one 
549 2922 50 174607-68-2 (1R)-1-[4-(benzyloxy)-3-(hydroxymethyl)phenyl]-2-(tert-butylamino)ethan-1-ol 
48 2922 50 196810-09-0 methyl N-(2-benzoylphenyl)-L-tyrosinate 
644 2922 50 653574-13-1 methyl N-(benzyloxycarbonyl)valyl-D-alloisoleucylthreonylnorvalinate 
379 2923 20 4235-95-4 1,2-dioleoyl-sn-glycero-3-phosphocholine 
377 2923 20 77286-66-9 2-O-methyl-1-O-octadecyl-sn-glycero-3-phosphocholine 
12 2924 19 89182-60-5 1-deoxy-1-formamidohexitol 
198 2924 19 162537-11-3 N-(methoxycarbonyl)-3-methyl-L-valine 
309 2924 19 186193-10-2 (2S)-2-{[3-(tert-butoxycarbonyl)-2,2-dimethylpropanoyl]oxy}-4-methylpentanoic acid 
378 2924 19 228706-30-7 1,2-dioleoyl-sn-glycero-3-phospho[N-(4-carboxybutanoyl)ethanolamine] 
487 2924 29 6485-67-2 (2R) -2-amino-2-phenylacetamide 
398 2924 29 22871-58-5 3-amino-5-[(2-hydroxyethyl)carbamoyl]-2,4,6-triiodobenzoic acid 
13 2924 29 28197-66-2 N- [3-acetyl-4-(oxiran-2-ylme thoxy)phenyl ]butanamide 
347 2924 29 35661-39-3 N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-alanine 
349 2924 29 35661-60-0 N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-leucine 
619 2924 29 40371-50-4 (2S)-4-{[(benzyloxy)carbonyl]amino}-2-hydroxybutanoic acid 
411 2924 29 49705-98-8 benzyl ((1S,2R)-1-carbamoyl-2-hydroxypropyl)carbamate 
144 2924 29 53947-84-5 2-( carboxyacetamido) benzoic acid 
371 2924 29 65864-22-4 L-phenylalaninamide 
350 2924 29 71989-14-5 4-tert-butyl N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-aspartate 
351 2924 29 71989-18-9 5-tert-butyl N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-glutamate  
Schedule XIV – Norway – Chemical Intermediates                                      Page 45                WT/Let/654 ID # HS code CAS-RN Preferred name 
353 2924 29 71989-20-3 N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-glutamine 
355 2924 29 71989-23-6 N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-isoleucine 
356 2924 29 71989-26-9 N6-(tert-butoxycarbonyl)-N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-lysine 
367 2924 29 71989-33-8 O-tert-butyl-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-serine 
368 2924 29 71989-35-0 O-tert-butyl-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-threonine 
370 2924 29 71989-38-3 O-tert-butyl-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-tyrosine 
412 2924 29 80082-51-5 3-amino-2-{[(benzyloxy)carbonyl]amino}-1-methyl-3-oxopropyl methanesulfonate 
197 2924 29 98760-08-8 tert-butyl [1-((2S)-oxiran-2-yl)-2-phenylethyl]carbamate 
352 2924 29 132327-80-1 N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-N5-trityl-L-glutamine 
348 2924 29 132388-59-1 N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-N4-trityl-L-asparagine 
183 2924 29 170361-49-6 N-(3,4-dichlorophenyl)-N-{3-[(2,3-dihydroinden-2-yl)methylamino]propyl}-5,6,7,8-tetrahydronaphthalene-2 -
carboxamide 
102 2924 29 194085-75-1 2-(2-chlorophenyl)-2-hydroxyethyl carbamate 
360 2924 29 244191-94-4 N-[(9H-fluoren-9-ylmethoxy)carbonyl]- α-L-glutamyl-N6-(tert-butoxycarbonyl)-L-lysyl-N-trityl-L-asparaginyl- α-L-
glutamyl-N-trityl-L-glutaminyl- α-L-glutamyl-L-leucyl-L-leucyl- α-L-glutamyl-L-leucine, 1,4,6,9-tetra-tert-butyl ester 
687 2924 29 325715-13-7 N-(3- acetylphenyl)-N-methylacetamide 
598 2924 29 376348-76-4 ethyl (3S)-3-(4,4-difluorocyclohexane-1-carboxamido)-3-phenylpropanoate 
599 2924 29 376348-77-5 4,4-difluoro-N-((1S)-3-hydroxy-1-phenylpropyl)cyclohexane-1-carboxamide 
600 2924 29 376348-78-6 4,4-difluoro-N-((1S)-3-oxo-1-phenylpropyl)cyclohexane-1-carboxamide 
731 2924 29 481659-97-6 tert-butyl {(1S)-2-[benzyl(methyl)amino]-2-oxo-1-phenylethyl}carbamate hydrochloride 
696 2924 29 667937-05-5 3-[4-(trifluoromethyl)anilino]pentanamide 
215 2925 20 3382-63-6 4-{(E)-[(4-fluorophenyl)imino]methyl}phenol 
317 2925 20 249561-98-6 tris{[(2Z)-2-chloro-3-(dimethylamino)prop-2-en-1-ylidene]dimethylammonium} hexafluorophosphate(3-) 
539 2926 90 28049-61-8 1-(4-chlorophenyl)cyclobutane-1-carbonitrile 
528 2926 90 31915-40-9 N- [1-cyano-2-(4-hydroxyphenyl )-1-methylethyl]acetamide 
938 2926 90 114772-54-2 4'-(bromomethyl)biphenyl-2-carbonitrile 
142 2926 90 152630-47-2 1-[3-(cyclopentyloxy)-4-methoxyphenyl]-4-oxocyclohexane-1-carbonitrile 
143 2926 90 152630-48-3 dimethyl 4-cyano-4-[3-(cyclopentyloxy)-4-methoxyphenyl]heptanedioate 
585 2926 90 192869-10-6 2-iodo-3,4-dimethoxy-6-nitrobenzonitrile 
586 2926 90 192869-24-2 6-amino-2-iodo-3,4-dimethoxybenzonitrile 
673 2926 90 474645-97-1 (3R)-3-aminopentanenitrile methanesulfonate 
803 2926 90 604784-44-3 tert-butylammonium (Z)-3-cyano-5-methylhex-3-enoate  
Schedule XIV – Norway – Chemical Intermediates                                        Page 46              WT/Let/654 ID # HS code CAS-RN Preferred name 
49 2928 00 618-26-8 1-methyl-1-phenylhydrazine sulfate (2:1) 
287 2928 00 212631-79-3 2-(2-chloro-4-iodoanilino) -N-(cyclopropylmethoxy)-3,4-difluorobenzamide 
33 2928 00 253605-31-1 N- hydroxy-2-methylprop an-2-amine acetate (salt)   or   tert-butylhydroxylamine acetate (salt) 
403 2929 90 204254-98-8 ethyl (3R, 4S,5R)-5-azido-3-(1-ethylpropoxy)-4-hydroxycyclohex-1-ene-1-carboxylate 
405 2929 90 204255-06-1 ethy l (3R,4R,5S)-4-acetam ido-5-azido-3-(1-ethylpropoxy)c yclohex-1-ene-1-carboxylate 
339 2930 90 2736-23-4 2,4-dichloro-5-mesylbenzoic acid 
358 2930 90 3483-12-3 (2R,3S)-1,4-disulfanylbutane-2,3-diol   or   dithiothreitol 
862 2930 90 15570-12-4 3-methoxybenzene-1-thiol 
56 2930 90 16188-55-9 [4-(methylsulfanyl)phenyl]acetic acid 
864 2930 90 40248-84-8 3-sulfanylphenol 
324 2930 90 50413-24-6 2-bromo-1-(4-mesylphenyl)ethan-1-one 
65 2930 90 90536-66-6 (4-mesylphenyl)acetic acid 
748 2930 90 104458-24-4 2-mesylethan-1-amine hydrochloride 
399 2930 90 153277-33-9 methyl N-[(benzyloxy)carbonyl]-S-phenyl-L-cysteinate 
26 2930 90 225652-11-9 1-(4-chlorophenoxy)-4-(methylsulfanyl)benzene   or   4-chlorophenyl 4-(methylsulfanyl)phenyl ether 
595 2930 90 289717-37-9 N,N-dimethyl-2-[4-(methylsulfanyl)phenoxy]benzylamine hydrochloride 
742 2930 90 346413-00-1  1-(4-ethoxyphenyl)-2-(4-mesylphenyl)ethan-1-one 
594 2930 90 364323-64-8 2-[4-(methylsulfanyl)phenoxy]benzaldehyde 
58 2931 00 27784-76-5 tert-but yl (diethoxypho sphoryl)acetate 
391 2931 00 86552-32-1 (4-phenylbutyl)phosphinic acid 
206 2931 00 123599-82-6 {[2-methyl-1-(propionyloxy)propoxy](4-phenylbutyl)phosphoryl}acetic acid 
789 2931 00 649761-22-8 (1R,5S)-5-[dimethyl(phenyl)silyl]-2-(hydroxymethyl)cyclopent-2-ene-1-carboxylic acid — (1R,2R)-2-amino- 1-(4-
nitrophenyl)propane-1,3-diol (1:1) (salt) 
747 2932 19 27329-70-0 (5-formyl-2-furyl)boronic acid 
762 2932 19 37076-71-4 1,2,3-tri-O-acetyl-5-deoxy-D-ribofuranose 
700 2932 19 87392-07-2 (2S)-tetrahydrofuran-2-carboxylic acid 
115 2932 29 51559-36-5 5-methoxy-2H-chromen-2-one 
660 2932 29 95716-70-4 7 α-(methoxycarbonyl)-3-oxo-17 α-pregna-4,9(11)-diene-21,17-carbolactone 
703 2932 29 96829-59-3 (1S,3E,6E)-1-[((2S,3S)-3-hexyl-4-oxooxetan-2-yl)methyl]dodeca-3,6-dien-1-yl N-formyl-L-leucinate 
582 2932 29 122111-01-7 [(2R)-2-(benzoyloxy)-4,4-difluoro-5-oxotetrahydrofuran-2-yl]methyl benzoate 
78 2932 29 142680-85-1 (25S)-25-cyclohexyl-25-de(sec-butyl)-5-O-demethyl-22,23-dihydroavermectin A 1a 
244 2932 29 145667-75-0     (3aR,4R,5R,6aS)-5-hydroxy-4-((3R)-3-hydroxy-5-phenylpentyl)hexahydrocyclopenta[b]furan-2-one  
Schedule XIV – Norway – Chemical Intermediates                                      Page 47                WT/Let/654 ID # HS code CAS-RN Preferred name 
79 2932 29 220119-16-4 (25S)-cyclohexyl-25-de(sec-butyl)- 5-demethoxy-5-oxo-22,23-dihydroavermectin A 1a 
942 2932 29 221129-55-1 (6R)-4-hydroxy-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-2-one 
62 2932 99 7772-94-3 2-acetamido-2-deoxy- β-D-mannopyranose 
11 2932 99 65293-32-5 N- β-D-glucopyranosylformamide 
607 2932 99 115437-18-8 (2 α, 4α, 5β,7β,10β,13β)-4-acetoxy-1,10,13-trihydroxy-9-oxo-7-[(triethylsilyl)oxy]-5,20-epoxytax-11-en-2-yl benzoate 
608 2932 99 115437-21-3 (4 α)-4,10-diacetoxy-1,13-dihydroxy-9-oxo-7-[(triethylsilyl)oxy]-5,20-epoxytax-11-en-2-yl benzoate 
37 2932 99 124655-09-0 te rt-butyl [(4R,6S)-6-(hy droxymethyl)-2,2-dimethyl- 1,3-dioxan-4-yl]acetate 
567 2932 99 130064-21-0 1-{2-hydroxy-4-[(tetrahydropyran-2-yl)oxy]phenyl}-2-{4-[(tetrahydropyran-2-yl)oxy]phenyl}ethan-1-one 
54 2932 99 130525-58-5 methyl 5-acetamido-7, 8,9-O-triacetyl-2,6-anhydro-4- azido-3,4,5-trideoxy-D-gly cero-D-galacto-non-2-enonat e 
609 2932 99 149107-93-7 (2 α, 4α, 5β, 7β,10β,13α)-4,10-diacetoxy-13-{[(2R,3S)-3-benzam ido-2-(1-methoxy-1 -methylethoxy)-3-
phenylpropanoyl]oxy}-1-hydroxy-9-oxo-7-[(triethylsilyl)oxy]-5,20-epoxytax-11-en-2-yl benzoate 
156 2932 99 167256-05-5 methyl (1S,2S)-1-(1,3-benzodioxol-5-yl)-3-(2-hydroxy-4-methoxyphenyl)-5-propoxyindane-2-carboxylate 
157 2932 99 191106-49-7 methyl (1S,2S)-1-(1,3-benzodioxol-5-yl)-3-[2-(benzyloxy)-4-methoxyphenyl]-5-propoxyindane-2-carboxylate  
189 2932 99 192201-93-7 2-({ 3-[5-(6-methoxy-1-naphthyl)- 1,3-dioxan-2-yl]pr opyl}methylamino)-N-methylacetamide 
127 2932 99 196303-01-2 (7S)-7-methyl-5-(4-nitrophenyl)-7,8-dihydro-5H-[1,3]dioxolo[4,5-g]isochromene 
652 2932 99 199796-52-6 (2 α, 4α, 7β, 10β,13α)-4,10-diacetoxy-13-({(2R,3S)-3-benzami do-2-[((4Z,7Z,10Z,1 3Z,16Z,19Z)-docosa-
4,7,10,13,16,19-hexaenoyl)oxy]-3-phenylpropanoyl}oxy)-1,7-dihydroxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate 
590 2933 19 334828-10-3 4-amino-5-ethyl-1-(2-methoxyethyl)pyrazole-3-carboxamide 
511 2933 21 186462-71-5 (1R,2R,5S,6R)-2',5'-dioxospiro[bicyclo[3.1.0]hexane-2,4'-imidazolidine]-6-carboxylic acid 
583 2933 29 68283-19-2 (2-butylimidazol-5-yl)methanol 
354 2933 29 109425-51-6 N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-N-trityl-L-histidine 
263 2933 29 178982-67-7 2-[(benzyloxy)methyl]-4-isopropylimidazole 
359 2933 29 244191-88-6 N- acetyl-O-tert-butyl-L-tyro syl-O-tert-butyl-L-thre onyl-O-tert-butyl-L-seryl -L-leucyl-L-isoleucyl-N1-trityl-L-histidyl-
O-tert-butyl-L-seryl-L-leucyl-L-isoleucyl- α-L-glutamyl- α-L-glutamyl-O-tert-butyl-L-seryl-N-trityl-L-glutaminyl-N-
trityl-L-asparaginyl-N-trityl- L-glutaminyl-L-glutamine, 10,11-di-tert-butyl ester 
365 2933 29 244244-26-6 N- acetyl-O-tert-butyl-L-tyro syl-O-tert-butyl-L-thre onyl-O-tert-butyl-L-seryl -L-leucyl-L-isoleucyl-N1- trityl-L-histidyl-
O-tert-butyl-L-seryl-L-leucyl-L-isoleucyl- α-L-glutamyl- α-L-glutamyl-O-tert-butyl-L-seryl-N-trityl-L-glutaminyl-N-
trityl-L-asparaginyl-N-trityl- L-glutaminyl-L-glutaminyl- α-L-glutamyl-N6-(tert-butoxycarbonyl)-L-lysyl-N-trityl-L-
asparaginyl- α-L-glutamyl-N-trityl-L-glutaminyl- α-L-glutamyl-L-leucyl-L-leucyl- α-L-glutamyl-L-leucyl- α-L-aspartyl-
N6-(tert-butoxycarbonyl)-L-lysyl-N1-(tert-butoxycarbonyl)-L-tryptophyl-L-al anyl-O-tert-butyl-L-seryl-L-leucyl-N1-
(tert-butoxycarbonyl)-L-tryptoph yl-N-trityl-L-asparaginyl-N1-(tert-butoxycarbonyl)-L-tryptophyl-L-phenylalaninamide, 
hepta-tert-butyl ester 
954 2933 39 0-00-0 11-ethyl-5-methyl-8-{2-[(1-oxo-1 λ4-quinolin-4-yl)oxy]et hyl}-11H-dipyrido[ 3,2-b:2’,3’-e][1,4] diazepin-6(5H)-one 
210 2933 39 4021-07-2 3-methylpyridine-2-carboxylic acid  
Schedule XIV – Norway – Chemical Intermediates                                        Page 48              WT/Let/654 ID # HS code CAS-RN Preferred name 
875 2933 39 19395-39-2 2-phen yl-2-piperidin-2-ylacetamide 
765 2933 39 25333-42-0 (3R)-quinuclidin-3-ol 
565 2933 39 26815-04-3 4-(2-piperidin-1-ylethoxy)benzaldehyde 
579 2933 39 37699-43-7 2,3-dimethyl-4-nitropyridine 1-oxide 
560 2933 39 43200-82-4 6-(5-chloropyridin-2-yl)-5H-pyrrolo[3,4-b]pyrazine-5,7(6H)-dione 
538 2933 39 58859-46-4 ethyl 4-aminopiperidine-1-carboxylate 
626 2933 39 78750-68-2 4-[(3-aminopyridin-2-yl)amino]phenol 
513 2933 39 84449-81-0 4-(2-piperidin-1-ylethoxy)benzoyl chloride hydrochloride 
119 2933 39 99 100238-42-4 4-(2-piperidin-1-ylethoxy)phenol 
541 2933 39 103129-82-4 3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarbox ylate 
167 2933 39 127293-57-6 (1R)-1-(4-chlorophenyl)-2-[4-(4-fluorobenzyl)piperidin-1-yl]ethan-1-ol 
16 2933 39 158878-47-8 (3R, 5R)-3-{(E)-2-[4-(4-fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)pyridin-3-yl]vinyl}-5-hydroxycycl ohexan-1-
one 
14 2933 39 159813-78-2 (3R, 5S,6E)-7-[4-(4-fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)pyridin-3-yl]-3,5-dihydroxyhept-6-eno ic acid 
621a 2933 39 161417-03-4 2-methyl-3-((2S)-pyrrolidin-2-ylmethoxy)pyridine 
9 2933 39 177964-68-0 3-[4-(4-fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)pyridin-3-yl]acrylaldehyde 
168 2933 39 178460-82-7 (1R)-1-(4-chlorophenyl)-2-[4-(4-fluorobenzyl)piperidin-1-yl]ethan-1-ol hydrochloride 
264 2933 39 178981-89-0 {5-[(3,5-dichlorophenyl)sulfanyl]-4-isopropyl-1-(pyridin-4-ylmethyl)imidazol-2-yl}methanol 
173 2933 39 188396-54-5 1-(2-biphenyl-4-ylethyl)-4-[3-(trifluoromethyl)phenyl]-1,2,3,6-tetrahydropyridine hydrochloride 
196 2933 39 198904-85-7 tert-butyl 2-(4-pyridin-2-ylbenzyl)hydrazine-1-carboxylate 
199 2933 39 198904-86-8 tert-butyl 2-{(2S, 3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-4-phenylbutyl}-2-[4-(pyridin-2-yl)benzy l]hydrazine-
1-carboxylate 
840 2933 39 213839-64-6 N-{2-[5-(aminoiminomethyl)-2-hydroxyphenoxy]-3,5-difluoro-6-[3- (1-methyl-4,5-dihydroimidazol-2-
yl)phenoxy]pyridin-4-yl]-N-methyglycine dihydrochloride 
442 2933 39 221180-26-3 4-amino-5-chloro-2-methoxy-N-(3-methoxypiperidin-4-yl)benzamide 
318 2933 39 221615-75-4 2-(4-mesylphenyl)-1-(6-methylpyridin-3-yl)- ethan-1-one 
690 2933 39 230615-52-8 2,3,4,5-tetrahydro-1H-1,5-methano-3-benzazepine hydrochloride 
661 2933 39 230615-59-5 7, 8-dinitro-3-(trifluo roacetyl)-2,3,4,5-tetrahydro-1 H-1,5-methano- 3-benzazepine 
842 2933 39 280129-82-0 4-({2-[(benzyloxy)methyl]-4-isopropylimidazol-1-yl}methyl)pyridine oxalate (1:2) 
490 2933 39 319460-85-0 N-methyl-2-{[3-((E)-2-pyridin-2-ylvinyl)-1H-indazol-6-yl]sulfanyl}benzamide 
489 2933 39 319460-94-1 N-(2-fluoro-5-{[3-((E)-2-pyridin-2-ylvin yl)-1H-indazol-6-yl]amino}phenyl)-1,3-dimethylpyrazole-5-carbox amide 
649 2933 39 423165-13-3 8-benzyl-3-exo-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octane 
951 2933 39 429659-01-8 ethyl N-[4-(methylamino)-3-nitrobenzoyl]-N-pyridin-2-yl-ß-alaninate  
Schedule XIV – Norway – Chemical Intermediates                                      Page 49                WT/Let/654 ID # HS code CAS-RN Preferred name 
564 2933 39 440634-25-3 tert-butyl 4-{2-[4-(mesyloxy)piperidin-1-yl]-2-oxoethyl}piperidine-1-carboxylate 
948 2933 49 0-00-0 2-(ethylamino)-5-[2-(quinolin-4-yloxy)ethyl]nicotinic acid 
153 2933 49 6340-55-2 2,6-dimethoxy-4-methylquinoline 
483 2933 49 10500-57-9 5,6,7,8-tetrahydroquinoline 
664 2933 49 79276-06-5 tert-butyl (3S)-1,2,3,4-tetrahydroisoquinoline-3-carboxylate 4-methylbenzenesulfonate 
149 2933 49 106635-86-3 2,6-dimethoxy-4-methyl-5-[3-(trifluoromethyl)phenoxy]quinolin-8-amine 
647 2933 49 118864-75-8 (1S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline 
36 2933 49 172649-40-0 3-[(4S)-5-oxo-2-(trifluoromethyl)-1,4,5,6,7,8-hexahydroquinolin-4-yl]benzonitrile 
623 2933 49 189279-58-1 1-(6-amino-3,5-difluoropyridin-2-yl)-8-chloro-6-fluoro-7-(3-hydroxyazetidin-1-yl)-4-oxo-1,4-dihydroquin oline-3-
carboxylic acid 
150 2933 49 189746-15-4 2,6-dimethoxy-4-methyl-8-nitro-5-[3-(trifluoromethyl)phenoxy]quinoline 
152 2933 49 189746-19-8 5-chloro-2,6-dimethoxy-4-methylquinoline 
151 2933 49 189746-21-2 5-chloro-2,6-dimethoxy-4-methyl-8-nitroquinoline 
434 2933 49 194804-45-0 ethyl 1-cyclopropyl-8-(difluoromethoxy)-7-((1R)-1-methyl-2-tritylisoindolin-5-yl)-4-oxo-1,4-dihydroquin oline-3-
carboxylate 
433 2933 49 194805-07-7 ethyl 7-bromo-1-cyclopropyl-8-(difluoromethoxy)-4-oxo-1,4-dihydroquinoline-3-carboxylate 
705A 2933 49 209909-03-5 (2-chloro-6,7-difluoroquinolin-3-yl)methanol 
704A 2933 49 220998-08-3 {2,7-dichloro-6-methyl-4-[(4 -methylpiperidin-1-yl)methyl]quinolin-3-yl}methanol 
386 2933 49 287930-77-2 (1S)-1-{3-[(E)-2-(7-chloroquinolin-2-yl)vinyl]phenyl}-3-[2-(1-hydroxy-1-methylethyl)phenyl]propan-1-ol 
387 2933 49 287930-78-3 methyl 2-((3S)-3-{3-[(E)-2-(7-chloroquinolin-2-yl)vinyl]phenyl}-3-hydroxypropyl)benzoate hydrate 
674 2933 49 474645-93-7 methyl [2-ethyl-6-(trifluoromethyl)-1,2,3,4-tetrahydroquinolin-4-yl]carbamate 
313 2933 59 487-21-8 pteridine-2,4(1H, 3H)-dione 
946 2933 59 7139-02-8 2,6-dichloro-4,8-dipiperidinopyrimido[5,4-d]pyrimidine 
531 2933 59 14080-23-0 pyrimidine-2-carbonitrile 
744 2933 59 16064-08-7 6-iodoquinazolin-4(1H)-one 
790 2933 59 19916-73-5 6-(benzyloxy)-9H-purin-2-amine 
949 2933 59 57061-71-9 1-(2-chloroethyl)-4-[3-(trifluoromethyl)phenyl]piperazine dihydrochloride 
561 2933 59 59878-63-6 6-(5-chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl piperazine-1-carboxylate 
455 2933 59 119532-26-2 1-(2,3-dichlorophenyl)piperazine 
80 2933 59 137234-74-3 4-chloro-6-ethyl-5-fluoropyrimidine 
509 2933 59 137281-39-1 4-[2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoic acid 
39 2933 59 140373-09-7 4-{[(3-{[(2,2-dimethylpropanoyl)oxy]methyl}-2,7-dimethyl-4-oxo-3,4-dihydroquinazolin-6-yl)methyl](prop-2 -yn-1-
yl)amino}-2-fluorobenzoic acid  
Schedule XIV – Norway – Chemical Intermediates                                        Page 50              WT/Let/654 ID # HS code CAS-RN Preferred name 
38 2933 59 160009-37-0 methyl 4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethanesulfonamido)]pyrimidine-5-carboxylate 
123 2933 59 167465-36-3 (2R)-1-[4-((1aR, 10bS)-1,1-difluoro-1,1a, 6,10b-tetrahydrodibenzo[a,e]cyclopropa[c][7]annulen-6-yl)pipe razin-1-yl]-3-
[(quinolin-5-yl)oxy]propan-2-ol trihydrochloride 
73 2933 59 188416-20-8 3-(6-chloro-5-fluoropyrimidin-4-yl)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol hydrochlo ride 
81 2933 59 188416-28-6 4-(1-bromoethyl)-6-chloro-5-fluoropyrimidine 
112 2933 59 192725-50-1 (2S)-3-methyl-2-(2-oxohexahydropyrimidin-1-yl)butanoic acid 
133 2933 59 192726-06-0 (2S)-N-[(1S, 3S, 4S)-4-amino-1-benzyl-3-hydroxy-5-phenylpentyl]-3-methyl-2-(2-oxotetrahydropyrimidin-1( 2H)-
yl)butanamide — 5-oxopyrrolidine-2-carboxylic acid (1:1) (salt) 
261 2933 59 214287-88-4 (4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-3,4-dihydroquinazolin-2(1H)-one 
259 2933 59 214287-99-7 (4S)-6-chloro-4-((E)-2-cyclopropylvinyl)-4-(trifluoromethyl)-3,4-dihydroquinazolin-2(1H)-one 
653 2933 59 225916-82-5 8-chloro-5-((4Z, 7Z, 10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl)-11-(4-methylpiperazin-1-yl)-5H-
dibenzo[b,e][1,4]diazepine 
746 2933 59 231278-20-9 N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-iodoquinazolin-4-amine 
256 2933 59 247565-04-4 (4S)-6-chloro-4-(cyclopropylethynyl)-3-((R)-1-phenylethyl)-4-(trifluoromethyl)-3,4-dihydroquinazolin-2( 1H)-one 
554 2933 59 345217-02-9 1-[(1S, 2S)-2-(benzyloxy)-1-ethylpropyl]-N-{4-[4-(4-hydroxyphenyl)piperazin-1-yl]phenyl}hydrazine-1-car boxamide 
958 2933 59 518048-03-8 2-(1-amino-1-methylethyl)-N-(4-fluorobenzyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidine-4-carboxami de 
830 2933 59 599179-03-0 1-(4,6-dimethylpyrimidine-5-carbonyl)- 
4-((3S)-4-{(1R)-2-methoxy-1-[4-(trifluoromethyl)phenyl]ethyl}-3-methylpiperazin-1-yl)-4-methylpiperidine maleate 
(1:1) 
828 2933 59 612494-10-7 1-{(1R)-2-methoxy-1-[4-(trifluoromethyl)phenyl]ethyl}-2-methylpiperazine D-tartarate (1:1) 
829 2933 59 612543-01-8 1-(4,6-dimethylpyrimidine-5-carbonyl)piperidin-4-one 
791 2933 59 649761-23-9 (1S,2S,3S,5S)-5-[2-amino-6-(benzyloxy)-9H-purin-9-yl]-2-[(benzyloxy)methyl]-3-[dimethyl(phenyl)silyl]-1 -
(hydroxymethyl)cyclopentan-1-ol 
792 2933 59 649761-24-0 2-amino-9-{(1S,3R,4S)-3-[(benzyloxy)methyl]-4-[dimethyl(phenyl)silyl]-2-methylidenecyclopentyl}-9H-puri n-6(1H)-
one 
835 2933 59 654671-77-9 (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-1-(2,4,5-triflu orophenyl)butan-
2-amine phosphate (1:1) hydrate 
148 2933 79 3197-25-9 2-(4-oxopentyl)-1H-isoindole-1,3(2H)-dione 
154 2933 79 5342-23-4 6-methoxy-4-methylquinolin-2(1H)-one 
713 2933 79 43200-81-3 6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one 
413 2933 79 80082-62-8 tetra butylammonium (2S,3S)- 3-{[(benzyloxy)car bonyl]amino}-2-methyl-4-o xoazetidine-1-sulfonate 
414 2933 79 80082-65-1 (2S,3S)-3-amino-2-methyl-4-oxoazetidine-1-sulfonic acid 
457 2933 79 105318-28-3 ((2S,3S)-2-{(1R)-2-[(4-chlorophenyl)sulfanyl]-1-methyl-2-oxoethyl}-3-((1R)-1-hydroxyethyl)-4-oxoazetidi n-1-
yl)acetic acid  
Schedule XIV – Norway – Chemical Intermediates                                      Page 51                WT/Let/654 ID # HS code CAS-RN Preferred name 
610 2933 79 133066-59-8  (3R,4S)-2-oxo-4-pheny lazetidin-3-yl acetate 
60 2933 79 148776-18-5 (2-oxo-1-phenylpyrrolidin-3-yl)triphenylphosphonium bromide 
612 2933 79 149107-92-6 1-be nzoyl-3-(1-met hoxy-1-methylet hoxy)-4-phenylazetidin-2-one 
692 2933 79 162142-14-5 1-cyclopentyl-3-ethyl-1,4,5,6-tetrahydro-7H-pyrazolo[3,4-c]pyridin-7-one 
50 2933 79 198213-15-9 sodium 3-(methoxycarbonyl)-2-oxo-1,2,5,6-tetrahydropyridin-4-olate 
188 2933 79 205881-86-3 6-fluoro-9-methyl-2-phenyl-4-(pyrrolidine-1-carbonyl)-9H-pyrido[3,4-b]indol-1(2H)-one 
176 2933 79 244080-24-8 1-ethyl-9-methoxy-2,6,7,12-tetrahydroindolo[2,3-a]quinolizin-4(3H)-one 
491 2933 79 283173-50-2 8-fluoro-2-{4-[(methylamino)meth yl]phenyl}-1,3,4,5-tet rahydro-6H-azepino[5, 4,3-cd]indol-6-one 
693 2933 79 303752-13-8 1-cyclopentyl-3-ethyl-6-(4-methoxybenzyl)-1,4,5,6-tetrahydro-7H-pyrazolo[3,4-c]pyridin-7-one 4-methylbe nzene-1-
sulfonate 
776 2933 79 341031-54-7 N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethylpyr role-3-
carboxamide L-malate (1:1) 
311 2933 99 5424-01-1 3-aminopyrazine-2-carboxylic acid 
223 2933 99 6548-09-0 5-bromotryptophan 
227 2933 99 14907-27-8 methyl D-tryptophanate hydrochloride 
312 2933 99 16298-03-6 methyl 3-aminopyrazine-2-carboxylate 
420 2933 99 31560-19-7 N-benzoyl-4-hydroxyproline 
421 2933 99 31560-20-0 methyl N-benzoyl-4-hydroxyprolinate 
91 2933 99 32065-66-0 2-(dimet hoxymethyl)quinoxaline 1,4-dioxide 
373 2933 99 39968-33-7 3H-[1,2,3]triazolo[4,5-b]pyridin-3-ol 
724 2933 99 61607-68-9  1-[2-(dimethylamino)ethyl]-4,5-dihydro-1H-tetrazole-5-thione 
488 2933 99 62893-24-7 (6-ethyl-4,5-dioxohexahydropyridazine-3-carboxamido)(4-hydroxyphenyl)acetic acid 
728 2933 99 71056-57-0 ethyl 1-methyl-5-nitroindole-2-carboxylate 
19 2933 99 75302-98-6 2-tert-butox y-2-oxoethyl [1-(4-chlorobenzoyl) -5-methoxy-2-methy lindol-3-yl]acetate 
537 2933 99 84946-20-3 2-chloro-1-(4-fluorobenzyl)benzimidazole hydrochloride 
72 2933 99 86404-63-9 1-(2,4-difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethan-1-one 
396 2933 99 92992-17-1 1-(m ethoxycarbonyl)-2,3-di hydro-1H-pyrrolizin e-7-carboxylic acid 
416 2933 99 96314-26-0 (4S)-4-phenyl-L-proline 
392 2933 99 103201-78-1 4-cyclohexylproline 
120 2933 99 113963-68-1 3,4-di(indol-3-yl)-1-methylpyrrole-2,5-dione 
322 2933 99 119192-10-8 4-[(1H-1,2,4-triazol-1-yl)methyl]aniline 
422 2933 99 120807-02-5 (4S)-N-benzoyl-4-(mesyloxy)-L-proline 
369 2933 99 143824-78-6 N1-(tert-butoxycarbonyl)-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-tryptophan  
Schedule XIV – Norway – Chemical Intermediates                                        Page 52              WT/Let/654 ID # HS code CAS-RN Preferred name 
4 2933 99 149365-59-3 dibenzyl 5,5'-[(3,4-diethylpyrrole-2,5-diyl)bis(methylene)]bis[4-(3-methoxy-3-oxopropyl)-3-methylpyrrole- 2-
carboxylate] 
5 2933 99 149365-62-8 5,5'-[(3,4-diethylpyrrole-2,5-diyl)bis(methylene)]bis[4-(3-hydroxypropyl)-3-methylpyrrole-2-carbaldehyde]  
940 2933 99 152628-02-9 1,4’-dimethyl-2’-propyl-1H, 1’H-2,6’-bibenzimidazole 
939 2933 99 152628-03-0 4-Methyl-2-propylbenzimidazole-6-carboxylic acid 
323 2933 99 160194-39-8 2-{5-[(1H-1,2,4-triazol-1-yl)methyl]indol-3-yl}ethan-1-ol 
35 2933 99 171964-73-1 [N-(4-methoxybenzoyl)-L-valyl]-N-[(1S)-3,3,3-trifluoro-1-isopropyl-2-oxopropyl]-L-prolinamide 
230 2933 99 172733-42-5 sodium [(1-benzy l-2-ethyl-3-oxamoyli ndol-4-yl)oxy]acetate 
87 2933 99 180637-89-2 3-[((2R)-1-methylpyrrolidin-2-yl)methyl]-5-[(E)-2-(phenylsulfonyl)vinyl]indole 
677 2933 99 180915-94-0 1-{2-[4-(6-methoxy-3,4-dihydro-1-naphthyl)phenoxy]ethyl}pyrrolidine 
676 2933 99 180915-95-1  1-{2-[4-(2-bromo-6-methoxy-3,4-dihydro-1-naphthyl)phenoxy]ethyl}pyrrolidine 
31 2933 99 181827-47-4 [N-(methoxycarbonyl)-L-valyl]-L-proline 
86 2933 99 188113-71-5 1-acet yl-3-[((2R)-1-methylpyrrolid in-2-yl)methyl]-5-[(E)-2-( phenylsulfonyl)vinyl]indole 
140 2933 99 193077-87-1 [(2S)-7-(2-methoxy-2-oxoethyl)-4-m ethyl-3-oxo-2,3,4 ,5-tetrahydro-1H-1,4-ben zodiazepin-2-yl]acetic acid 
27 2933 99 193274-37-2 3a-benzyl-2-methyl-2,3a,4,5,6,7-hexahydro-3H-pyrazolo[4,3-c]pyridin-3-one L-tartarate 
137 2933 99 197143-35-4 (3Z)-4-(aminomethyl)pyrrolidin-3-one O-methyloxime dihydrochloride 
404 2933 99 204255-02-7 ethyl (1R, 5R, 6R)-5-(1-ethylpropoxy)-7-azabicyclo[4.1.0]hept-3-ene-3-carboxylate 
139 2933 99 210288-67-8 [( 2S)-7-iodo-4-methyl-3-oxo-2 ,3,4,5-tetrahydro- 1H-1,4-benzodiazepin -2-yl]acetic acid 
794 2933 99  210558-66-0 (1R,2S)-1-phenyl-2-pyrrolidin-1-ylpropan-1-ol hydrochloride 
319 2933 99 219909-83-8 3-((4S)-4-sulfanyl-L-prolinamidol)benzoic acid hydrochloride 
634 2933 99 221030-56-4 2-(4-fluorophenyl)-4-(3-hydroxy-3-methylbutoxy)-5-(4-mesylphenyl)pyridazin-3(2H)-one 
743 2933 99 221148-46-5 2-(4-ethoxyphenyl)-3-(4-mesylphenyl)pyrazolo[1,5-b]pyridazine 
245 2933 99 227025-33-4 1-benzyl-4H-imidazo[4,5,1-ij]quinolin-2(1H)-one 
441 2933 99 235106-62-4 2,2'-[(4-hydroxyphenyl)methylene]bis(4-{(E)-[(5-methyl-1H-tetrazol-1-yl)imino]methyl}phenol) 
362 2933 99 244191-95-5 α-L-aspartyl-N6-(tert-butoxycarbonyl)-L-lysyl-N1-(tert-butoxycarbonyl)-L-tryptophyl-L-alanyl-O-tert-butyl-L-seryl-L-
leucyl-N1-(tert-butoxycarbonyl)-L-tryptophyl-N-trityl-L-asparaginyl-N1-(tert-butoxycarbonyl)-L-tryptophyl-L-
phenylalaninamide, tert-butyl ester 
361 2933 99 244191-96-6 N-[(9H-fluoren-9-ylmethoxy)carbonyl]- α-L-aspartyl-N6-(tert-butoxycarbonyl)-L-lysyl-N1-(tert-butoxycarbonyl)-L-
tryptophyl-L-alanyl-O-tert-butyl-L-seryl-L-leucyl-N1-(tert-butoxycarbonyl)-L-tryptophyl-N-trityl-L-asparaginyl-N1-
(tert-butoxycarbonyl)-L-tryptophan, 1-tert-butyl ester 
363 2933 99 244244-29-9 N-[(9H-fluoren-9-ylmethoxy)carbonyl]- α-L-glutamyl-N6-(tert-butoxycarbonyl)-L-lysyl-N-trityl-L-asparaginyl- α-L-
glutamyl-N-trityl-L-glutaminyl- α-L-glutamyl-L-leucyl-L-leucyl- α-L-glutamyl-L-leucyl- α-L-aspartyl-N6-(tert-
butoxycarbonyl)-L-lysyl-N1-(tert-butoxycarbonyl)-L-tryptophyl-L- alanyl-O-tert-butyl-L-seryl-L-leucyl-N1-(tert-
butoxycarbonyl)-L-tryptophyl-N-trityl-L-asparaginyl-N1-(tert-butoxycarbonyl)-L-trypt ophyl-L-phenyl alaninamide,  
Schedule XIV – Norway – Chemical Intermediates                                      Page 53                WT/Let/654 ID # HS code CAS-RN Preferred name 
penta-tert-butyl ester 
364 2933 99 244244-31-3 α-L-glutamyl-N6-(tert-butoxycarbonyl)-L-lysyl-N-trityl-L-asparaginyl- α-L-glutamyl-N-trityl-L-glutaminyl- α-L-
glutamyl-L-leucyl-L-leucyl- α-L-glutamyl-L-leucyl- α-L-aspartyl-N6-(tert-butoxycarbonyl)-L-lysyl-N1-(tert-
butoxycarbonyl)-L-tryptophyl-L-alanyl- O-tert-butyl-L-seryl-L-leucyl-N1-(tert-butoxycarbonyl)-L -tryptophyl-N-trityl-L-
asparaginyl-N1-(tert-butoxycarbonyl)-L-tryptophyl-L-phenylalaninamide, penta-tert-butyl ester monohydrochloride 
646 2933 99 251579-55-2 (N -acetyl-N-methylglycyl)glycylvalyl- D-alloisoleucylthreonylnorvalylisol eucylarginyl(N-ethylprolinamide ) 
monoacetate (salt) 
581 2933 99 252742-72-6 5-(chloromethyl)-1,2-dihydro-3H-1,2,4-triazol-3-one 
246 2933 99 269731-84-2 (5R, 6R)-1-benzyl-5-hydroxy-6-(methylamino)-5,6-dihydro-4H-imidazo[4,5,1-ij]quinolin-2(1H)-one 
563 2933 99 272107-22-9 3,10-dibromo-8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridine 
741 2933 99 346412-97-3 1-aminopyridazinium hexafluorophosphate(1-) 
645 2933 99 442526-89-8 isoleucylarginyl(N-ethylprolinamide) dihydrochloride 
729 2933 99 481659-93-2 ethyl 1-methyl-5-[4'-(trifluoromethyl)biphenyl-2-carboxamido]indole-2-carboxylate 
730 2933 99 481659-96-5 potassium 1-methyl-5-[4'-(trifluoromethyl)biphenyl-2-carboxamido]indole-2-carboxylate 
723 2934 10 29676-71-9 (2-amino-1,3-thiazol-4-yl)acetic acid 
338 2934 10 34272-64-5 (4-methyl-2-sulfanyl-1,3-thiazol-5-yl)acetic acid 
415 2934 10 88023-65-8 potassium 3-[(2 -formamido-1,3-thi azol-4-yl)oxoacetamido]-2-methy l-4-oxoazetidine-1-sulfonate 
737 2934 10 115065-79-7 (2E)-2-(2-{[(benzyloxy)carbonyl]amino}-1,3-thiazol-4-yl)-5-[(3-methylbut-2-en-1-yl)oxy]-5-oxopent-2-eno ic acid 
651 2934 10 136401-69-9 (Z)-5-{4-[2-(5-ethylpyridin-2-yl)ethoxy]benzylidene}-1,3-thiazolidine-2,4-dione 
643 2934 10 161798-03-4 ethyl 2-(3-formyl-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate 
485 2934 10 162208-27-7 O-[2-(2-amino-1,3-thiazol-4-yl)-2-((Z)-methoxyimino)acetyl] O,O-diethyl phosphorothioate 
725 2934 10 162208-28-8  O-(2-( 2-aminothiazol-4-yl)-2-{[ 1-(tert-butoxycarbonyl)-1 -methylethoxy]imino}acetyl ) O’,O’’-diethyl pho sphorothioate 
46 2934 10 179258-52-7 tert-butyl (7Z)-7-(2-amino-1,3-thiazol-5-yl)-4-ethoxy-10,10-dimethyl-6-oxo-3,5,9-trioxa-8-aza-4-phosphau ndec-7-en-
11-oate 4-oxide 
247 2934 10 186538-00-1 3-[(2S, 3S)-2-hydroxy-3-(3-hydroxy-2-methylbenzamido)-4-phenylbutanoyl]-5,5-dimethyl-N-(2-methylbenzyl) -1,3-
thiazolidine-4-carboxamide 
104 2934 10 189448-35-9 (7R) -7-[(2E)-2-(2-amino-5-chloro -1,3-thiazol-4-yl)-2-(hydroxy imino)acetamido] -3-[(3-{[(2-
aminoethyl)sulfanyl]methyl}pyridin-4-yl)sulfanyl]-3,4-didehydrocepham-4-carboxylic acid 
388 2934 10 213252-19-8 5-[(2,4-dioxo-1,3-thiazolidin-5-yl)methyl]-2-methoxy-N-[4-(trifluoromethyl)benzyl]benzamide  
Schedule XIV – Norway – Chemical Intermediates                                        Page 54              WT/Let/654 ID # HS code CAS-RN Preferred name 
178 2934 10 221671-63-2 potassium (2-{N-[4-(4-chloro-2,5-dimethoxyphenyl)-5-(2-cyclohexylethyl)-1,3-thiazol-2-yl]carbamoyl}-5,7 -
dimethylindolin-1-yl)acetate 
111 2934 10 224631-15-6 2,5-dioxopyrrolidin-1-yl N-{N-[(2-isopropyl-1,3-thiazol-4-yl)methyl]-N-methylcarbamoyl}-L-valinate 
871 2934 10 302962-49-8 N-(2-chloro-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)thiaz ole-5-
carboxamide or   dasatanib (proposed INN) 
859 2934 10 478410-84-3 (4R)-N-allyl-3-[(2S,3S)-2-hydroxy-3-(3-hydroxy-2-methylbenzamido)-4-phenylbutanoyl]-5,5-dimethylthiazol idine-4-
carboxamide 
957 2934 99 0-00-0 potassium 5-methyl-1,3,4-oxadiazole-2-carboxylate 
584 2934 99 98-03-3 thiophene-2-carbaldehyde 
665 2934 99 7481-90-5 1-(3,5-anhydro-2-deoxy- β-D-threo-pentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione 
451 2934 99 11389-01-3 diphenylmethyl (2S,5R)-6,6-dibromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate 4- oxide 
767 2934 99 13636-02-7 (RS)-3-(dimethylamino)-1-(2-thienyl)propan-1-ol 
656 2934 99 18686-82-3 1,3,4-thiadiazole-2-thiol 
446 2934 99 20893-30-5  2-thienylacetonitrile 
722 2934 99 24209-43-6  (7R)-7-amino-3-[2-(1,3,4-thiadiazol-2-ylsulfanyl)ethyl]-3,4-didehydrocepham-4-carboxylic acid 
325 2934 99 30165-96-9 4-(4-chloro-1,2,5-thiadiazol-3-yl)morpholine 
448 2934 99 36923-17-8 (7R)-7-amino-3,4-didehydrocepham-4-carboxylic acid 
717 2934 99 37539-03-0 (7R)-7-amino-3-[(1H-1,2,3-triazol-4-ylsulfanyl)methyl]-3,4-didehydrocepham-4-carboxylic acid 
655 2934 99 53994-69-7 (7R)-7-amino-3-chloro-3,4-didehydrocepham-4-carboxylic acid 
719 2934 99 61807-78-1 7-(bromo acetamido)-7-methoxy-3-{ [(1-methyl-1H-tetrazol-5-yl)lsulfany l]methyl}-3,4-didehydrocepham-4-carb oxylic 
acid 
738 2934 99 63457-21-6 diphenylmethyl 2-(3-benzyl-7-oxo-4-thia-2,6-diazabicyclo[3.2.0]hept-2-en-6-yl)-3-methylbut-3-enoate 
721 2934 99 68350-02-7  (7R)-7-amino-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-3,4-didehydrocepham-4-carboxylic acid hydr ochloride 
718 2934 99 70035-75-5 diphenyl methyl (7S)-7-(br omoacetamido)-7-methoxy-3-{[(1-methyl-1 H-tetrazol-5-yl)sul fanyl]methyl}-3,4-
didehydrocepham-4-carboxylate 
208 2934 99 75776-79-3 1,4-dithia-7-azaspiro[4.4]nonane-8-carboxylic acid hydrobromide 
93 2934 99 76646-91-8 (3S)-6,6-dibromo-2,2-dimethylpenam-3-carboxylic acid 1,1-dioxide 
90 2934 99 76801-85-9 (2R, 3S, 4R, 5R,8R,10R,11R,12S,13S,14R)-13-[(2,6-dideoxy-3-C-methyl-3-O-methyl- α-L-ribo-hexopyranosyl)oxy]-2-
ethyl-3,4,10-trihydroxy-3,5,8,10,12,14-hexamethyl-11-{[3,4,6-trideoxy-3-(dimethylamino)- β-D-xylo-
hexopyranosyl]oxy}-1-oxa- 6-azacyclopentadecan-15-one 
716 2934 99 79349-82-9 trans-(7R)-7-amino-3-vinyl-3,4-didehydrocepham-4-carboxylic acid 
243 2934 99 86639-52-3 (4S)-4,11-diethyl-4,9-dihydroxy-1H,12H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione 
342 2934 99 92096-37-2 diph enylmethyl (7R)-3-(mesyloxy)-7-(phenyl acetamido)-3,4-d idehydrocepham-4-carboxylate  
Schedule XIV – Norway – Chemical Intermediates                                      Page 55                WT/Let/654 ID # HS code CAS-RN Preferred name 
525 2934 99 93183-15-4 2'-deoxy-5'-O-(4,4’-dimethoxytrityl)-N2-isobutyrylguanosine 3'-(2-cyanoethyl diisopropylphosphoramidite) 
688 2934 99 96219-87-3 (3-aminopyrazol-4-yl)(2-thienyl)methanone 
526 2934 99 98796-51-1 2'-deoxy-5'-O-(4,4’-dimethoxytrityl)thymidine 3'-(2-cyanoethyl diisopropylphosphoramidite) 
527 2934 99 98796-53-3 N6-benzoyl-2'-deoxy-5'-O-(4,4’-dimethoxytrityl)adenosine 3'-(2-cyanoethyl diisopropylphosphoramidite) 
517 2934 99 98819-76-2 (2S)-2-[(S)-(2-ethoxyphenoxy)phenylmethyl]morpholine 
53 2934 99 100988-63-4 1-[((7R)-7-amino-4-carboxy-3,4-didehydrocepham-3-yl)methyl]pyridinium iodide 
520 2934 99 102212-98-6 N4-benzoyl-2'-deoxy-5'-O-(4 ,4’-dimethoxytrityl)cytidi ne 3'-(2-cyanoethyl diisopropylphosphoramidite) 
795 2934 99 103788-59-6 4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]benzaldehyde 
55 2934 99 103788-65-4 2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethan-1-ol 
618 2934 99 110483-43-7 2'-bromo-2'-deoxy-5-methyluridine 3',5'-diacetate 
735 2934 99 114341-88-7   3-(2-bromopropanoyl)-4,4-dimethyl-1,3-oxazolidin-2-one 
770 2934 99 116539-55-0 (1S)-3-(methylamino)-1-(2-thienyl)propan-1-ol 
343 2934 99 127111-98-2 diphenylmethyl (7R)-7-amino-3-(mesyloxy)-3,4-didehydrocepham-4-carboxylate hydrochloride 
439 2934 99 130800-76-9 5-(3-chloropropyl)-3-methylisoxazole 
260 2934 99 134379-77-4 4-amino-5-fluoro-1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]pyrimidin-2(1H)-one 
447 2934 99 135790-89-5 [(2,2-dimethylpropanoyl)oxy]methyl (7R)-7-[(2Z)-2-(2-{(2S)-2-[(tert-butoxycarbonyl)amino]propanamido}-1 ,3-
thiazol-4-yl)-2-(methoxyimino)acetami do]-3,4-didehydrocepham-4-carboxylate 
344 2934 99 140128-37-6 di phenylmethyl (7R)-7-(2-{2-[(tert- butoxycarbonyl)amino]-1 ,3-thiazol-4-yl}-2- [( trityloxy)imino]acetami do)-3-({[(1H-
1,2,3-triazol-4-yl)sulfanyl]methyl}sulfanyl)-3,4-didehydrocepham-4-carboxylate 
177 2934 99 155990-20-8 N-[(1-{[2-(diethylamino)ethyl]amino}-7-methoxy-9-oxo-9H-thioxanthen-4-yl)methyl]formamide 
8 2934 99 158878-46-7 6-{(E)-2-[4-(4-fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)pyridin-3-yl]vinyl}-4-hydroxytetrahydro-2H- pyran-2-
one 
771 2934 99 164015-32-1 N-methyl-3-(1-naphthyloxy)-2-(2-thienyl)propan-1-amine phosphate 
815A 2934 99 170985-86-1 1-[(2S, 3S)-2-(benzyloxy)pentan-3-yl]-4-(4-{4-[4-({(3R,5R)-5-(2,4-difluorophenyl)-5-[(1H-1,2,4-triazol-1-
yl)methyl]tetrahydrofuran-3-yl}methoxy)phenyl]piperazin-1-yl}phenyl)-1H-1,2,4-triazol-5(4H)-one 
382 2934 99 171482-05-6 (2R,3S)-2-{(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}-3-(4-fluorophenyl)morpholine hydrochloride 
181 2934 99 176773-87-8 (3R)-3-(methoxymethyl)-7-(4,4,4-trifluorobutoxy)-3,3a,4,5-tetrahydro[1,3]oxazolo[3,4-a]quinolin-1-one 
278A 2934 99 177587-08-5 N-{5-[2-((6S)-2-a mino-4-oxo-3,4,5,6,7,8-hexahy dropyrido[2,3-d]pyrimidin-6-yl)ethyl]-4-methylthiophene- 2-
carbonyl}-L-glutamic acid 
175 2934 99 181640-09-5 3-(1-{2-[4-benzoyl-2-(3,4-difluorophenyl)morpholin-2-yl]ethyl}-4-phenylpiperidin-4-yl)-1,1-dimethylurea  
hydrochloride 
125 2934 99 182133-09-1 6-(benzyloxy)-3-bromo-2-(4-methoxyphenyl)-1-benzothiophene 1-oxide 
659 2934 99 183433-66-1 [6-chloro-4-(2-ethyl-1,3-dioxolan-2-yl)-2-methoxypyridin-3-yl]methanol  
Schedule XIV – Norway – Chemical Intermediates                                        Page 56              WT/Let/654 ID # HS code CAS-RN Preferred name 
242 2934 99 183434-04-0 tert-butyl (4S)-4-ethyl-4,6-dihydroxy-3 ,10-dioxo-3,4,8,10-tetrahydro-1H-pyrano[3,4-f]indolizine-7-carbo xylate 
182 2934 99 185835-97-6 (5S)-5-(methoxymethyl)-3-[6-(4,4,4-trifluorobutoxy)-1,2-benzoxazol-3-yl]-1,3-oxazolidin-2-one 
185 2934 99 186348-69-6 7-chloro -8-[((2R)-1,4-diazabicyclo [2.2.2]octan-2-yl)methyl amino]-2,3-dihydro-1,4 -benzodioxine-5-carboxa mide 
252 2934 99 188016-51-5  methyl N-(butoxycarbonyl)-3-{[(5 R)-3-(4-cyanophenyl)-4,5 -dihydroisoxazol- 5-yl]acetamido}-L-alaninate 
187 2934 99 189003-92-7 2-{7-fluoro-2-oxo-4- [2-(4-thieno[3,2-c]pyridin- 4-ylpiperazin-1-yl)ethyl] quinolin-1(2H)-yl}acetamide 
216 2934 99 189028-95-3 (4S)-3-[(5R)-5-(4-fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidin-2-one 
186 2934 99 191023-43-5 5-(8-amino-7-chloro-2,3-dihydro-1,4-benzodioxin-5-yl)-3-(1-phenethylpiperidin-4-yl)-1,3,4-oxadiazol-2(3 H)-one 
697 2934 99 192049-49-3 4-nitrobenzyl 2-((1R, 5R)-3-benzyl-7-oxo-4-thia-2,6-diazabicyclo[3.2.0]hept-2-en-6-yl)-3-methylbut-2-en oate 
327 2934 99 194861-99-9 ((5S)-3-tert-butyl-2-phenyl-1,3-oxazolidin-5-yl)methanol 
627 2934 99 195708-14-6 (2R, 3R, 4S)-4-(1,3-benzodioxol-5-yl)-3-(ethoxycarbonyl)-2-(4-methoxyphenyl)pyrrolidinium (2S)-
hydroxy(phenyl)acetate 
340 2934 99 197897-11-3 1-[((7R)-7-amino-4-carboxy-3,4-didehydrocepham-3-yl)methyl]-1H-imidazo[1,2-b]pyridazin-4-ium iodide 
30 2934 99 199327-61-2 7-methoxy-6-(3-morpholinopropoxy)quinazolin-4(3H)-one 
310 2934 99 204990-60-3 (3S, 10R, 13Z, 16S)-10-(3-chloro-4-methoxybenzyl)-3-isobutyl-6,6-dimethyl-16-[(1S)-1-((2R, 3R)-3-phenyl oxiran-2-
yl)ethyl]-1,4-dioxa-8,11-diazacyclohexadec-13-ene-2,5,9,12-tetrone 
704B 2934 99 220997-99-9 (5R)-9-chloro-5-ethyl-5-hydroxy-10-methyl-12-[(4-methylpiperidin-1-yl)methyl]-1,4,5,13-tetrahydro-3H, 15H-
oxepino[3', 4':6,7]indolizino[1,2-b]quinoline-3,15-dione hydrochloride 
704 2934 99 221054-70-2 (5R)-5-ethyl-5-hydroxy-1,4,5,8-tetrahydrooxepino[3,4-c]pyridine-3,9-dione 
184 2934 99 223570-85-2 8-methyl-8-azabicyclo[3.2.1]octan-3-yl 2,3-dihydropyrazolo[1,5,4-de][1,4]benzoxazine-6-carboxylate 
432 2934 99 223595-20-8 (1R)-5-(1,3,6,2-dioxazaborocan-2-yl)-1-methyl-2-tritylisoindoline 
707 2934 99 227029-27-8 2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethyl methanesulfonate 
299 2934 99 227625-35-6 3-{[2-(aminomethyl)cyclohexyl]methyl}-1,2,4-oxadiazol-5(4H)-one 
298 2934 99 227626-65-5 tert-butyl N-methyl-N-{2-[(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)methyl]cyclohexyl}carbamate 
299A 2934 99 227626-75-7 3-{[2-(aminomethyl)cyclohexyl]methyl}-1,2,4-oxadiazol-5(4H)-one hydrochloride 
300 2934 99 229336-92-9  3-chloro-N-{4-chloro-2-[(5-chloropyridin-2-yl)carbamoyl]-6-methoxyphenyl}-4-{[2-(methylamino)imidazol- 1-
yl]methyl}thiophene-2-carboxamide 
300A 2934 99 229340-73-2 3-chloro-N-{4-chloro-2-[(5-chloropyridin-2-yl)carbamoyl]-6-methoxyphenyl}-4-{[2-(methylamino)imidazol- 1-
yl]methyl}thiophene-2-car boxamide trif luoroacetate 
82 2934 99 252317-48-9 {(3S )-1-[1-(2,3-dihydro-1 -benzofuran-5-yl)eth yl]pyrrolidin -3-yl}diphenylacetonitrile 
289 2934 99 253450-09-8 6-({2-[4-(4-fluorobenzyl)piperidin-1-yl]ethyl}sulfinyl)-1,3-benzoxazol-2(3H)-one 
841 2934 99 253450-12-3 6-{[2-(4-benzylpiperidin-1-yl)ethyl] sulfinyl}-1,3-benzoxazol-2(3H)-one 
408 2934 99 287737-72-8 (2S)-hydroxy(phenyl)acetic acid — (1S)-3-(dimethylamino)-1-(2-thienyl)propan-1-ol (1:1) (salt) 
383 2934 99 287930-73-8 4-benzyl-2-hydroxymorpholin-3-one  
Schedule XIV – Norway – Chemical Intermediates                                      Page 57                WT/Let/654 ID # HS code CAS-RN Preferred name 
384 2934 99 287930-75-0 (2R)-4-benzyl-2-{(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}morpholin-3-one 
815 2934 99 345217-03-0  2-[(2S, 3S)-2-(benzyloxy)pentan-3-yl]-4-(4-{4-[4-({(3R,5R)-5-(2,4-difluorophenyl)-5-[(1H-1,2,4-triazol-1-
yl)methyl]tetrahydrofuran-3-yl}methoxy)phenyl]piperazin-1-yl}phenyl)semicarbazide 
854 2934 99 362543-73-5 DNA, d(P-thio) (C-T-A-G-A-T-T-T-C-C-C-G-C-G), tridecasodium salt 
832 2934 99 377727-87-2 2-(2-furyl)-7-(2-{4-[4-(2-methoxyethoxy)phenyl]piperazin-1-yl}ethyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[2,3-
c]pyrimidin-5-amine 
706B 2934 99 475479-34-6 (2S)-2-methoxy-3-{4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-1-benzothiophen-7-yl}propanoic acid 
706 2934 99 475480-88-7 4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-1-benzothiophene-7-carbaldehyde 
959 2934 99 518048-05-0 potassium 4-[N-(2-fluorobenzyl)carbamoyl]-1-methyl-2-[1-methyl-1-(5-methyl-1,3,4-oxadiazole-2-carboxami do)ethyl]-
6-oxo-1,6-dihydropyrimidine-5-olate 
707A 2934 99 521266-46-6 (2S)-1-{N-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethyl]glycyl}pyrrolidine-2-carbonitrile 
961 2934 99 635724-55-9 (2S)-2-[(S)-(2-ethoxyphenoxy)phenylmethyl]morpholine  succinate 
797 2934 99 649761-25-1 methyl N-{4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]benzyl}glycinate hydrochloride 
702 2934 99 655233-39-9 4-nitrobenzyl (7R)-7-amino-3-((2S)-tetrahydrofuran-2-yl)-3,4-didehydrocepham-4-carboxylate hydrochlorid e 
769 2934 99 663603-70-1 (2Z)-3-(methylamino)-1-(2-thienyl)prop-2-en-1-one 
855 2934 99  744239-10-9 DNA, d(P-thio) (G-A-T-C-C-G-C-G-G-G-A-A-A-T), tridecasodium salt 
952 2934 99 872728-82-0 N-[4-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)phenyl]glycine 
70 2935 00 88933-16-8 1-(4-hydrazinophenyl)-N-methylmethanesulfonamide hydrochloride 
179 2935 00 137431-02-8 N-[3-(2-amino-1-hydroxyethyl)-4-fluorophenyl]methanesulfonamide 
626a 2935 00 141430-65-1 N-[2-(4-hydroxyanilin o)pyridin-3-yl]-4-methoxybenzene-1-sulfonamide 
329 2935 00 149490-60-8 N-(butane-1-sulfonyl)-L-tyrosine 
328 2935 00 149490-61-9 N-(butane-1-sulfonyl)-O-(4-pyridin-4-ylbutyl)-L-tyrosine 
40 2935 00 160231-69-6 (3S)-tetrahydrofuran-3-yl N-[(2S, 3R)-3-hydroxy-4-(N-isobutyl-4-nitrobenzene-1-sulfonamido)-1-phenylbuta n-2-
yl]carbamate 
562 2935 00 169280-56-2 4-amino-N-[(2R, 3S)-3-amino-2-hydroxy-4-phenylbutyl]-N-isobutylbenzene-1-sulfonamide 
711 2935 00 170569-88-7 4-[5-(4-fluorophenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzene-1-sulfonamide 
691 2935 00 186497-07-4 N-(3-methoxy-5-methylpyrazin-2-yl)-2-[4-(1,3,4-oxadiazol-2-yl)phenyl]pyridine-3-sulfonamide 
180 2935 00 189814-01-5 3-(2-amino-1-hydroxyethyl)-4-methoxybenzene-1-sulfonamide 
88 2935 00 200575-15-1 4-[2-ethoxy-5-(4-methylpiperazine-1-sulfonyl)benzamido]-1-methyl-3-propylpyrazole-5-carboxamide 
587 2935 00 210538-75-3 N-(1,2,3,4-tetrahydroisoquinolin-5-yl)methanesulfonamide hydrochloride 
41 2935 00 244634-31-9 N-((2R, 3S)-3-amino-2-hydroxy-4-phenylbutyl)-N-isobutyl-4-nitrobenzene-1-sulfonamide hydrochloride 
75 2935 00 247582-73-6 2-ethoxy-5-(4-ethylpiperazine-1-sulfonyl]nicotinic acid  
Schedule XIV – Norway – Chemical Intermediates                                        Page 58              WT/Let/654 ID # HS code CAS-RN Preferred name 
224 2935 00 289042-12-2 (4R, 6S)-6-((E)-2-{4-(4-fluorophenyl)-6-isopropyl-2-[mesyl(methyl)amino]pyrimidin-5-yl}vinyl)-2,2-dimet hyl-1,3-
dioxan-4-yl 3,3-dimethylbutanoate 
592 2935 00 334826-98-1 5-[2-ethoxy-5-(4-ethylpiperazine-1-sulfonyl)pyridin-3-yl]-3-ethyl-2-(2-methoxyethyl)-2,3,4,5,6,7-
hexahydropyrazolo[4,3-d]pyrimidin-7-one 
593 2935 00 334827-99-5 5-[2-ethoxy-5-(4-ethylpiperazine-1-sulfonyl)pyridin-3-yl]-3-ethyl-2-(2-methoxyethyl)-2,3,4,5,6,7-
hexahydropyrazolo[4,3-d]pyrimidin-7-one 4-methylbenzene-1-sulfonate 
591 2935 00 334828-19-2 N-[3-carbamoyl-5-ethyl-1-(2-methoxyethyl)pyrazol-4-yl]-2-ethoxy-5-[(4-ethylpiperazin-1-yl)sulfonyl]nico tinamide 
596 2935 00 364321-71-1 3-[(dimethylamino)methyl]-4-[4-(methylsulfanyl)phenoxy]benzene-1-sulfonamide 
597 2935 00 364323-49-9 3-[(dimethylamino)methyl]-4-[4-(methylsulfanyl)phenoxy]benzene-1-sulfonamide L-tartarate (1:1) 
335 2938 90 517-43-1 mixture of sennoside A and B 
336 2938 90 52730-36-6, 
52730-37-7 mixture of sennoside A and B, calcium salts 
882 2939 19 58-00-4 (6aR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol   or   apomorphine 
666 2939 29 467430-13-3 2-[2-methyl-1-(propionyloxy)propoxy]-2-[(4-phenylbutyl)phosphinoyl]acetic acid, (9R)-cinchonan-9-ol sal t (1:1) 
616 2940 00 6564-72-3 2,3,4,6-tetra-O-benzyl-D-glucopyranose 
617 2940 00 270071-40-4 benzyl 2,6-dimethoxy-4-{(5R, 5aR, 8aR,9S)-6-oxo-9-[(2,3,4,6-tetra-O-benzyl- β-D-glucopyranosyl)oxy]-5,5a,6,8,8a,9-
hexahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-5-yl}phenyl carbonate 
667 2940 00 471863-88-4 2,3-di-O-benzyl-4,6-O-((1R)-ethylidene)-D-xylo-hexopyranose 
668 2940 00 473799-30-3 (5S, 5aS, 9S)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a, 6,8,8a, 9-hexahydrofuro[3',4':6,7]naphtho[2 ,3-
d][1,3]dioxol-5-yl 2,3-di-O-benzyl-4,6-O-[(1R)-ethylidene]- β-D-glucopyranoside 
15 2941 90 19130-96-2 (2S,3S,4R,5R)-2-(hydroxymethyl)piperidine-3,4,5-triol 
200 2941 90 54122-50-8 dicy clohexylammmonium (7R)-3-(acetoxymethyl)-7-[ 2-({(3R)-3-[(tert-bu toxycarbonyl)amino]-3-
carboxypropyl}amino)-2-oxoethyl]-3,4-didehydrocepham-4-carboxylate or cephalosporin D dicyclohexylamine salt 
131 3002 10 42617-41-4 Blood-coagulation factor XIVa 
326 3824 90 30165-96-9 4-(4-chloro-1,2,5-thiadiazol-3-yl)morpholine, toluene solution 
409 3824 90 38345-66-3 (2S,3R)-4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-ol, toluene solution 
132 3824 90 84449-81-0 4-[2-(piperidin-1-yl)ethoxy]benzoyl chloride hydrochloride, 1,2-dichloroethane solution 
321 3824 90 127852-28-2 (1R)-1-[3,5-bis(trifluoromethyl)phe nyl]ethan-1-ol, acet onitrile solution 
510 3824 90 170277-77-7 (3S)-3-[2-(mesyloxy)ethoxy]-4-(trityloxy)butyl methanesulfonate, dimethylformamide solution 
 
  
_________